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ABSTRACT 
Courtney L. Kuhl 
Corporate Giving and Getting: Executive Perceptions at Healthcare Corporations 
(Under the direction of Elizabeth Dougall) 
 
Through qualitative in-depth interviews, healthcare industry executives explain that 
corporate giving is based on the mission and culture of an organization, benefiting employee 
and community relations and enhancing the core business. While difficult to tie to the bottom 
line, corporate giving can help establish partnerships and relationships that benefit the 
commercial interests of the corporation.  This multi-step series of actions is organized in this 
study using the corporate giving process model. Of the executives interviewed in this study, 
all agreed that their companies’ giving is becoming more strategic over time.  As companies 
begin to realize the potential of corporate giving to fulfill business goals, patterns of giving 
are becoming more strategically focused. Emerging from this study is the industry-partner-
impact model of corporate giving that the author contends is worthy of further investigation 
in healthcare and other industries. 
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CHAPTER I 
INTRODUCTION 
 
For more than 40 years, scholars and business professionals alike have struggled to 
define corporate social responsibility. From equal opportunity employment to environmental 
stewardship to altruistic philanthropy, definitions and concepts amass into a tremendous body 
of academic research and corporate practice (Carroll, 2000).    
Adam Smith first wrote a book in 1863 entitled, An Inquiry into the Nature and 
Causes of the Wealth of Nations. He argued that businesses that pursue profit will produce 
the greatest social good because of the “invisible hand” of the marketplace. Andrew Carnegie 
wrote The Gospel of Wealth in 1889 and brought religious thinking to social responsibility—
the charity principle is to assist the less fortunate members of our society. The stewardship 
principle is to be a caretaker—both of financial resources for shareholders and for the 
economic resources of society (Lantos, 2001).  
Fast-forward to 1969, and in a landmark speech at the Harvard Business School, 
Henry Ford II argued that the “terms of the contract between industry and society are 
changing… Now we are being asked to serve a wider range of human values and to accept an 
obligation to members of the public with whom we have no commercial transactions” 
(Lantos, 2001, p. 597). A year later, in 1970, Milton Friedman wrote his seminal article for 
the New York Times and famously stated the only responsibility of business is to make a 
profit for its shareholders (Friedman, 1970). Ford and Friedman’s comments must be 
interpreted in the context of the decades in which they were stated, that is the 1960s and 
21970s when major social reforms led to the public to make more demands on corporations 
than ever before. A tidal wave of anti-business sentiment flooded the social environment 
(Clark, 2000). People became more aware of employment laws and ethics, the environment, 
civil rights, and other social issues—all of which led to an expectation that if society 
supported business, then business should in turn support society by behaving responsibly.  
American business institutions function within a social system. The 
system confers legitimacy on business institutions [and] defines the bounds and 
rules of their performance… The conclusion is inescapable that the corporation 
receives its permission to operate from a society and ultimately is accountable 
to the society for what it does and how it does it. (Anshen, 1980, p. 6) 
 
During that time, society maintained high expectations of responsibility from government 
and corporations because they were the two largest institutions in our country. Still a widely 
held sentiment today, society expects corporations to step in to help cure its ills where the 
government falls short (Burke & Logsdon, 1996).  
As these new expectations of corporations emerged, the study of corporate social 
responsibly also grew. Scholars began a conversation—or perhaps a debate—about the 
responsibilities of business, how they should be defined, and how they benefit both the 
corporation and society.  
A subset of the conversation about corporate social responsibility is corporate giving. 
Many view the phrase “corporate giving” itself to be an oxymoron because of the perception 
that corporations are out to make money, not give it away. Corporate giving, however, is an 
increasingly important element of corporate social responsibility. The most recent 
conversations on the topic pertain to the strategic significance of corporate giving and its use 
as a tool to manage a corporation’s stakeholders. Altruistic or strategic, corporate giving 
3exists as a popular corporate practice and a much-studied aspect of corporate social 
responsibility (McWilliams, Siegel, & Wright, 2006).  
Purpose of Study 
 The purpose of this study is to understand how executives at healthcare corporations 
view corporate giving at their institutions, how strategic they consider the giving to be, and 
how giving relates to the CSR commitment of the organization.  
Key Definitions 
 Several terms will be used in relation to corporate social responsibility and giving 
throughout this thesis. The meanings of each term, and the specific context in which they will 
be used for this study, are now explained.   
Corporate giving.  Carroll (1979) outlined the four categories of corporate social 
responsibility: economic, legal, ethical, and discretionary responsibility. Carroll (1983) later 
refined the discretionary area of responsibility to mean the voluntary or philanthropic 
activities of an organization. Philanthropy promotes human welfare and goodwill, and may 
be given in the form of financial resources, time of employees, contributions to the arts, 
community, or education (Carroll, 1991). In this thesis, the term corporate giving will be 
used similarly, that is, giving that promotes human welfare and goodwill and is not 
necessarily tied to a strategic business objective.  
Strategic giving. Many scholars debate the strategy that motivates corporate giving. 
Most scholars agree that corporate giving is motivated by the desire to achieve a strategic 
business goal; for example, enhancing corporate image or boosting employee morale (Burke 
& Logsdon, 1996). The purpose of this thesis is to understand executive perceptions of the 
4strategy (if any) behind corporate giving. Therefore, in this thesis, the term strategic giving is 
defined as corporate giving that is motivated by a strategic business objective.  
Healthcare corporation. In this thesis, healthcare corporation describes corporations 
that provide medical products to healthcare workers and patients. These corporations include 
pharmaceutical companies, biotechnology companies, and medical supply companies. For 
the purpose of this thesis, excluded corporations are health insurance companies, hospital 
chains, healthcare consulting firms, and companies that do not directly supply products for 
patient use.  
Healthcare industry. A broader term than healthcare corporation, the healthcare 
industry refers to all players in the healthcare environment, from patients to caregivers to 
companies—private, public, for-profit, nonprofit, or others—that support any facet of 
healthcare.  
Stakeholder. Stakeholders of a corporation include customers, employees, the 
government, financial analysts, local citizens, industry members, suppliers, competitors, and 
stockholders, among others. This thesis will use Freeman’s (1984) definition of a stakeholder 
as individuals and groups who affect and are affected by actions of the corporation.  
Corporate social responsibility (CSR). This study will use Carroll’s (1979) definition 
of CSR as “the economic, legal, ethical, and discretionary expectations that society has of an 
organization at a given point in time” (p. 500). While written in 1979, Carroll provides a 
concise and descriptive definition of CSR.  
These definitions are provided to clarify concepts presented in this thesis. The next 
section will provide background on the healthcare industry and why it is important to study.   
 
5Background 
The healthcare industry is overwhelming in scope, from patients to doctors and 
nurses, researchers to pharmaceutical marketers; it is a world unto itself. At the center of this 
world is the ethical and noble mission to support the health and wellbeing of humans.  
The focus of this thesis is the perceptions of executives from pharmaceutical, 
biotechnology, and medical supply companies. These firms are but one part of the healthcare 
industry, but they are vital—and sometimes controversial—players. Executives within these 
corporations face a unique set of challenges: they operate in a highly regulated environment, 
spend a disproportionate amount of money on research and development, and face myriad 
marketing challenges. Many are rewarded with hefty profits, but the industry is volatile, and 
a highly profitable year can quickly turn into a year of equally large losses (Arndt, 2004).  
As highly visible companies, healthcare corporations also face public pressure about 
the purpose and practice of companies in the industry. The public sees astonishing profits and 
becomes skeptical of the companies, fueled by their often-negative press (Feki, 2005).  
Healthcare corporations also face pressure because of the inherent value and risks of their 
products: they literally save lives—and occasionally precipitate death. As demand for 
products increases, so too does the pressure on the industry (Feki, 2005).   
Corporate social responsibility takes on a whole new meaning in a life-and-death 
industry. The products of these corporations do serve society, and therefore the industry has a 
unique opportunity to be strategic when it comes to how they donate products and a share of 
their profits. The position is unique not only because of the value of the products to society, 
but also because the mission of the companies is often somewhat philanthropic in nature. For 
example, Merck’s website states: “Our business is preserving and improving human life” 
6(http://www.merck.com/about/mission.html). There is a philanthropic bent to this statement, 
just as there is in Bristol Myers Squibb’s mission: “Our company’s mission is to extend and 
enhance human life by providing the highest-quality pharmaceutical and related health care 
products” (http://bristolmyerssquibb.com/aboutbms/content/data/ourple.html). If the goal of 
strategic giving is to serve both the beneficiaries of philanthropy and serve the corporate 
mission (Bruch & Walter, 2005), then healthcare companies enjoy an enormous opportunity 
to give back to society while serving their core business.  
The Chronicle of Philanthropy, in its corporate giving survey, cites the top five 
corporate donors of cash and products as Pfizer, Merck, Bristol-Myers Squibb, Johnson & 
Johnson, and Microsoft, in that order. The top four corporate donors are all healthcare 
companies. The Chronicle of Philanthropy began its corporate giving survey in 1993, and 
Pfizer is the first company to report giving more than $1 billion in cash and products in a 
single year (Wilhelm, Kerkman, & Moore, 2005).  These statistics are astonishing: a single 
industry dominates the top five list of corporate donors. Clearly corporate giving is a high 
priority for these healthcare companies—and understanding their motivations to be at the top 
of this giving hierarchy may help explain the strategic nature of CSR.  
The volatile and critical nature of the industry makes it ripe for study. Its public 
visibility, strategic opportunities, and sheer amount of giving make it perhaps the single most 
interesting industry to study when it comes to corporate giving. How these corporations 
decide to conduct their business can have life-or-death implications for patients, and profit-
or-fail implications for the corporations themselves. These extremes are fascinating, and this 
study seeks to understand one small part of these corporations: how executives perceive 
corporate social responsibility and corporate giving. These concepts connect the corporation 
7to its stakeholders, and understanding perceptions of executives will offer a small window 
into the healthcare corporations themselves.  
 
CHAPTER II 
LITERATURE REVIEW 
 
The Corporation 
 
An important first step in any review of the scholarly work on corporate social 
responsibility is to consider the concept of the corporation itself. Carroll (1979) summarized: 
Before anything else, the business institution is the basic economic unit 
in our society. As such it has a responsibility to produce goods and services that 
society wants and to sell them at a profit. All other business roles are predicated 
on this fundamental assumption. (p. 500)   
 
Scholars agree with Carroll in that the corporation must first make a profit to fulfill any of its 
responsibilities.  
 In addition to achieving profits, a corporation also has legal and ethical 
responsibilities, and commitments to a variety of stakeholders (Carroll, 1991). A stakeholder 
is defined as “any individual or group who can affect or is affected by the action, decisions, 
policies, practices, or goals of the organization” (Carroll, 1996, p. 74). Some scholars argue 
the only important stakeholder is the shareholder (Friedman, 1970), and others expand the 
definition to include any constituency who affects or is affected by the corporation (Freeman, 
1984).   Stakeholders of a corporation may include customers, employees, the government, 
financial analysts, local citizens, industry members, suppliers, competitors, and stockholders, 
among others. The theories of these responsibilities will be addressed, but first we must 
review the general expectations of society on business.  
 At a minimum, society expects corporations to make safe products, practice just 
hiring and human relations, and treat stakeholders fairly (Heath & Vasquez, 2001). Judd 
9(1995) discussed the status of corporations as “special citizens in the social system” because 
in addition to complying with laws about safety and employment, they must also use their 
power appropriately to support public policy (p. 40). Van Buren (1995) argues that 
corporations must make contributions to society to help sustain social, political, and 
economic justice; it is only with this stable environment that the corporation will enjoy a 
financial return. A “healthy societal atmosphere” must exist in order for a functioning market 
to exist, and therefore, this atmosphere precipitates successful companies (Pruzan, 2001, p. 
60). Carroll (1991) discusses this stability in terms of the internal ability of the corporation to 
balance commitments between the owners, or shareholders, and the various other 
stakeholders who have legal and ethical rights.   
 Lantos (2001) and Pruzan (2001) noted the rise of ethical consumerism in the late 
1990s. Consumers recognize their own responsibilities and their ability to influence corporate 
behavior. “Time after time surveys indicate that while shareholders are primarily concerned 
with corporate profitability, consumers, the primary source of corporate income, are 
increasingly concerned with the environmental, social, and ethical responsibility of business” 
(Pruzan, 2001, p. 52). Matten and Crane (2005) maintain that executives lack a clear 
understanding of what society wants from their company and do not understand the demands 
of ethical consumerism.  
 In the end, most scholars in the CSR field make the argument that social 
responsibility is, indeed, tied to the bottom line (Bovet, 1994; Burke & Logsdon, 1996; 
Frankental, 2001; Lantos, 2001; Tokarski, 1999). A company should be humane to all of its 
constituencies because any constituency that has contact with a corporation can affect its 
bottom line (Bovet, 1994). This notion is from stakeholder theory, which says that a 
10 
 
corporation’s stakeholders affect and are affected by the corporation (Freeman, 1984). This 
theory will be discussed at length later in the literature review.  Some companies are 
beginning to conduct social audits in addition to financial audits, but the explicit links 
between social good and profits remain elusive (Lantos, 2001). Although scholarship about 
corporate responsibility is important, its practice will ultimately marry the social and 
financial benefits. 
 After understanding the contentious foundation of CSR—that it is a highly debated 
concept important to corporations, individuals, and society—it is important to understand the 
conceptual development of this topic. Much of the theory about CSR represents not just how 
we think about business, but also how we view our collective society.  
Early Theory Development in Corporate Social Responsibility 
Theories about corporate social responsibility generally fall into four categories—
instrumental, political, integrative, and ethical (Garriga & Mele, 2004). Instrumental theories 
view the corporation solely as an instrument of profit. Political theories describe a 
responsible use of power in the political arena. Theories requiring corporations to incorporate 
social demands into their business functions are integrative. Other theories focus on the 
ethical commitment of the corporate world (Garriga & Mele, 2004).  
While Adam Smith, Andrew Carnegie, and others talked about business, wealth, and 
philanthropy more than 100 years ago, the acknowledged beginning of contemporary theory 
about CSR is attributed to Milton Friedman (1970) who argued that the only responsibility of 
a corporation is to turn a profit for shareholders. Friedman (1970) viewed any considerations 
of philanthropy as undermining a free market, arguing that if a corporation gave money to a 
community with the motivation of attracting desirable employees, then it was not practicing 
11 
 
social responsibility, it was simply fulfilling its own self-interests. While he staunchly 
disapproved of so-called philanthropy, Friedman advocated that firms stay within “the rules 
of the game,” that is, obeying laws and practicing basic ethics, in order to further a free 
market devoid of corporate fraud and deception (p. 126).  
Carroll (1979, 1983, 1991, 1996, 1990, 2000), perhaps the most well-known scholar 
in CSR research, presented a three-dimensional model of CSR. He focused on the social 
issues a company should address and the strategic social response to those issues. Carroll 
recognized that CSR, rather than being ultimately defined by a scholar or business person, 
should be defined by a company itself on a number of levels: the definition, the relevant 
social issues, and the response to those issues. 
Most importantly, Carroll (1979) outlined the “economic, legal, ethical and 
discretionary categories of business performance” (p. 499). These categories can be seen on a 
hierarchy—or at least a progression—from the basic, regulated functions of a company to 
those in which it has individual, strategic discretion as to how to contribute to society. Carroll 
made the delineation between required social responsibility (that which is bound by law) and 
that which is not required, but is expected by society, such as ethical treatment of employees 
and philanthropic efforts towards a society. A highlight of the theory is its requirement for 
social responsiveness. “The assumption is made here that business does have a social 
responsibility and that the prime focus is not on management accepting a moral obligation 
but on the degree and kind of managerial action” (Carroll, 1979, p. 501). In fact, firms that 
made large philanthropic contributions after committing crimes were found to fare better 
with the public than those corporations who simply obeyed the laws (Wokutch & Spencer, 
1987).  
12 
 
Carroll (1991, 1993) twice refined his theory to clarify the meaning of discretionary 
social responsibility. Carroll (1983) broke down the concept of CSR into four parts: 
economic, legal, ethical and voluntary or philanthropic.  Discretionary CSR encompasses the 
voluntary or philanthropic parts of the definition of CSR. Carroll’s (1991) second 
clarification introduced a pyramid of CSR that reflected the Committee for Economic 
Development’s “three concentric circles” model of CSR (p. 39). The core of the circle 
consisted of the economic functions of a corporation; the middle circle couched economic 
functions within social values; the outer circle encompassed “amorphorous responsibilities” 
of corporations to improve the social environment (p. 39). Carroll (1991) considered the 
philanthropic category of CSR as “icing on the cake” once the company met its economic, 
legal, and ethical responsibilities (p. 42). Philanthropy promotes human welfare and 
goodwill, and may be given in the form of financial resources, time of employees, 
contributions to the arts, community, or education.  
Carroll (1991) clarified that philanthropy resided at the top of his pyramid of CSR. 
After this clarification, he contended that: 
The total corporate social responsibility of business entails the 
simultaneous fulfillment of the firm’s economic, legal, ethical, and 
philanthropic responsibilities. Stated in more pragmatic and managerial terms, 
the CSR firm should strive to make a profit, obey the law, be ethical, and be a 
good corporate citizen.” (p. 42) 
 
Factors affecting the organization’s CSR include the firm’s size, mission, management 
philosophy, corporate strategy, industry characteristics, and state of the economy (Carroll, 
1991).  
Carroll (1979) set the stage for much of the theoretical study of CSR. Recent 
contributions to the study of CSR will be discussed in a forthcoming section of this literature 
13 
 
review. Before delving into current CSR theories, the next section will discuss stakeholder 
theory, which is fundamental to corporate social responsibility and the conceptual framework 
for this study.  
Stakeholder Theory 
Freeman (1984) weighed in with an important theoretical framework for studying 
CSR called stakeholder theory. This theory states that firms have relationships with myriad 
constituent groups including shareholders, consumers, employees, the government, and 
communities. These stakeholders affect and are affected by actions of the corporation. 
Therefore, corporations must consider stakeholders in all corporate strategy and functions 
and work to build relationships with stakeholders in order to be successful.  
In the past 20 years, stakeholder theory has developed to describe the relationships 
between corporations and society (Buchholz & Rosenthal, 2005). Corporations manage 
stakeholders by taking into account stakeholder views when making decisions. Stakeholders 
include customers, employees, the government, financial analysts, local citizens, industry 
members, suppliers, competitor, and stockholders, among others. Buchholz and Rosenthal 
(2005) also explain that stakeholder theory incorporates a relational theory of the firm:  
Stakeholder theory embodies in its very nature a relational view of the 
firm which incorporates the reciprocal dynamics of community, and its power 
lies in focusing management decision making on the multiplicity and diversity 
of the relationships within which the corporation has its being, and the 
multipurpose nature of the corporation as a vehicle for enriching these 
relationships in their various dimensions. (p. 144)  
 
Buchholz and Rosenthal (2005) argue that the corporation is never isolated from its 
stakeholders, “but is in fact constituted by the multiple relationships in which it is embedded 
and which give it its very being” (p. 147). The function of the corporation is to enrich these 
14 
 
relationships and internalize the perspectives of the stakeholders in order to achieve corporate 
growth and success.  
 As discussed earlier, Friedman (1970) said that the only responsibility of a 
corporation is to make a profit for shareholders. Stakeholder theory refutes Friedman and 
contends that a corporation is responsible to all of its stakeholders, not just shareholders. The 
theory also says that a corporation’s function and success is based on it relationships with all 
stakeholders (Kaler, 2003).  
 In their critical work to advance and explicate stakeholder theory, Donaldson and 
Preston (1995) described the theory as descriptive, instrumental, normative, and managerial. 
Stakeholder theory is descriptive because it explains what the corporation is: “a constellation 
of cooperative and competitive interests possessing intrinsic value” (p. 66). The theory is 
instrumental because it links a corporation’s management of stakeholders to corporate 
performance goals. It is normative and accepts that stakeholders have legitimate interest in a 
particular corporation, that stakeholders are identified by this interest, and that their interest 
merits consideration by the corporation. Finally, stakeholder theory is managerial because it 
recommends a corporation’s response to stakeholders.  
 Stakeholder theory underpins the theoretical framework of this thesis because of its 
role as a dominant paradigm in any research exploring the social responsibilities of the firm. 
The following section discusses additional theory development about corporate social 
responsibility developed in the 1990s and beyond. The theme of stakeholder importance 
resonates through all the theories discussed.  
15 
 
Contemporary Theory in Corporate Social Responsibility 
Many CSR theories developed in the 1990s integrated economics and ethics. Jones 
(1995) wrote that if firms are ethical, they will gain competitive advantage because they will 
build long-term, productive relationships with stakeholders. This approach furthers the 
thinking on stakeholder theory: a firm affects and is affected by stakeholders, and building 
relationships with stakeholders benefits all involved. Carroll’s (1977) theory on CSP, or 
corporate social responsiveness, was empirically tested by Waddock and Graves (1997). 
Their study found a positive association between CSP and financial performance—a 
promising finding due to the failure, at this point, to quantitatively link a corporation’s social 
commitment to its finances (Frankental, 2001). Russo and Fouts (1997) also found CSP led 
to competitive advantage, especially in high-growth industries such as the technology sector 
because it can help to distinguish a corporation in the minds of consumers relative to 
competition.  
 Theory moved from Friedman’s (1970) position that profit is the only responsibility, 
to Carroll’s four-part definition of CSR, to stakeholder theory, to the integration of 
economics and ethics. Further theory development looks to define CSR as an investment for 
the corporation. McWilliams and Siegel (2001) studied CSR through a supply and demand 
framework. In other words, they look at CSR from a resource perspective, and they define 
CSR as an investment (or input) that can result in beneficial outputs for the company. They 
also conceptualized CSR as a tool of competitive advantage, especially in helping a company 
differentiate its products for consumers. In particular, they noted that pharmaceutical 
companies have highly differentiated products (each drug addresses a specific patient need) 
and are therefore likely to use CSR initiatives to aid in that differentiation. Finally, 
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McWilliams and Siegel (2001), determined that the ideal level of investment in CSR is when 
it creates a neutral relationship with financial performance, as determined through a cost-
benefit analysis. CSR should enhance financial performance, not detract from it.  
 Having discussed contemporary CSR theories, I now address why corporations 
engage in corporate social responsibility.  
Why Corporations Engage in Corporate Social Responsibility 
The failure to find empirical evidence linking socially responsible business to 
financial performance plagues the study and practice of CSR. Although many scholars and 
countless organizations make the effort to find empirical evidence, proof is elusive (Burke & 
Logsdon, 1996). While frustrating, perhaps this is why the area receives so much attention in 
the academic and corporate worlds.  
Research discusses the “social contract” companies have with society (Lantos, 2001, 
p. 599). Scholars have also studied the concept of a dual- or triple-bottom line that 
encompasses financial, social, and environmental performance of a company (Lantos, 2001; 
Frankental, 2001). The practice of CSR can often help manage social and environmental 
performance, and this performance affects a corporation’s success. Companies practice CSR 
for many reasons, but two often-cited motives to engage in CSR are boosting employee 
morale and enhancing corporate image.  
Anand (2002) holds that corporate image and its link to financial performance is 
motivation behind practicing CSR: 
These efforts [CSR] will go a long way in building up the goodwill of a 
company, altering public perceptions, and communication to the government, 
company employees, shareholders, customers, and the media that it is a 
company with a strong set of values, a company that can be trusted, and 
therefore a company others would respect and want to do business with. (p. 176) 
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Pruzan (2001) argues that employee morale is another reason to incorporate CSR activities: 
Employee pride in the workplace is becoming an increasingly important 
indicator of effectiveness. The opposite is even more true: in those companies 
where the employees are not proud of their employer, there is a lack of trust, 
confidence, enthusiasm, and willingness to offer one’s best. (p. 54) 
 
Other reasons why corporations are motivated to practice CSR include a favorable view of 
philanthropic companies by consumers (Mullen, 1997). Companies can also strategically 
draw attention to issues through CSR activities that they may not be able to draw attention to 
through traditional marketing (Esrock & Leichty, 1998).  
After looking at what may motivate a company to practice CSR, it must be 
determined who within the company is responsible for those activities. Research denotes a 
difference in a company’s view of CSR with regard to whom in the company is ultimately 
responsible for its practices. Decisions about CSR activities may reside with executive 
committees or public relations departments. Alternatively they may not be assigned to a 
particular group, or may be handled by a cross-department committee. Where the decision-
making power for CSR activities resides is indicative of a company’s commitment to CSR 
(Frankental, 2001).  Research shows that companies with CEOs from a sales and marketing 
background often rate higher in corporate responsibility than those corporations with CEOs 
from manufacturing or engineering backgrounds (Heath & Vasquez, 2001).    
Having established some of the motivations for corporations to be socially 
responsible, I now discuss an important subset of the literature on CSR and the focus of this 
thesis: corporate giving.  
Corporate and Strategic Giving 
As discussed earlier, Carroll (1979) outlined four categories of corporate social 
responsibility: economic, legal, ethical, and discretionary responsibility. Carroll (1983) later 
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refined the discretionary area of responsibility to mean voluntary or philanthropic activities 
of an organization. Philanthropy promotes human welfare and goodwill, and may be given in 
the form of financial resources, time of employees, contributions to the arts, community, or 
education (Carroll, 1991). In this thesis, Carroll’s definition of philanthropy is used to 
describe corporate giving: giving that promotes human welfare and goodwill and is not 
necessarily tied to a strategic business objective.  
McWilliams, Siegel, and Wright (2006) summarized why corporate giving is an 
especially interesting subset of CSR to study: CSR as a whole is still in its embryonic stage— 
it is in a continuing state of emergence. We cannot measure what we cannot define, and 
therefore current research is looking more to the motivations of CSR, how it creates 
competitive advantage, and other issues of strategic importance. Corporate giving is a 
considered by many to be a strategic tool that corporations use to manage stakeholder 
relationships (Brammer & Millington, 2004). Due to the strategic opportunities it provides, 
corporate giving is a popular area of academic study and corporate practice.  
 While the two are related, corporate giving is different from strategic giving, and the 
two are not interchangeable terms. Many scholars debate the strategy that motivates 
corporate giving, but would agree that corporate giving is often motivated by the desire to 
achieve a strategic business goal; for example, enhancing corporate image or boosting 
employee morale (Burke & Logsdon, 1996). The purpose of this thesis is to understand 
executive perceptions of the strategy (if any) behind corporate giving. Therefore, in this 
thesis, the term strategic giving is defined as corporate giving that is motivated by a strategic 
business objective.  
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Many developing theories about CSR make the assumption that companies will 
adhere to sound economic, legal, and ethical practices. The debate becomes heated, however, 
when scholars and corporations discuss philanthropic CSR, or corporate giving. Most argue 
that corporations should not give away money without a strategic purpose. For example, 
Burke and Logsdon (1996) said a company should only invest in CSR that shows a return on 
investment; they argue that a corporation needs to understand that giving should fulfill a 
strategic business purpose:  
A strategic reorientation of the firm’s CSR philosophy can support its 
financial interests as well as other stakeholders’ interests in the firm. How to 
reorient CSR toward a more strategic perspective is the key to inspiring more 
CSR activities, thus serving stakeholder and societal interests more fully. (p. 
495) 
 
In other words, philanthropy can be strategic, and in fact, it should be strategic so that the 
corporation is benefiting from its investment (Burke & Logsdon, 1996).    
Burke and Logsdon (1996) asserted that through centrality, specificity, proactivity, 
voluntarism, and visibility, companies can make an investment in strategic giving that brings 
economic value to the company. If strategic giving—of time, money, or other resources to 
groups outside the corporation—fits with a company’s goals, mission, and vision, it will 
further the business interests of the firm. For example, a pharmaceutical company’s support 
of a health issue makes sense, while giving to the arts may not be as appropriate. 
Specifically, Burke and Logsdon (1996) outlined five strategic outcomes: customer loyalty, 
future purchase, new products, new markets, and productivity gains. They argue corporations 
should measure the economic value CSR activities create for the corporation—and to 
constantly scan the environment to anticipate changes and opportunities among social issues 
to ensure its CSR activities remain strategically relevant and economically viable. 
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Strategic giving is practiced to accomplish strategic business goals (Lantos, 2001). As 
explained by Porter and Kramer (2002), “There is no inherent contradiction between 
improving competitive context and making a sincere commitment to bettering society” (p. 
68). Many scholars concur that that strategic giving is a competitive tool, and finding the 
areas of overlap between social and economic value that enhance the competitiveness of a 
corporation is a respectable practice of CSR. Strategic giving is “effective and necessary in 
enhancing corporate objectives while serving societal causes in order to survive in the 
business world today” (Tokarski, 1999, p. 34). Strategic giving is a competitive tool in the 
forms of corporate image enhancement, boosting employee morale, consumer connection 
with the firm, and even positive press coverage (Porter & Kramer, 2002). 
Many companies lack a truly strategic giving program, and most find it nearly 
impossible to measure the results (Tokarski, 1999).  Some form of measurement is important, 
especially because poorly managed strategic giving can be damaging if the program does not 
align with the goals, mission, and values of the corporation (Tokarski, 1999). This study will 
help to address the extent that strategic business objectives motivate corporate giving.  
Bruch and Walter (2005) stated that the only sustainable approach to corporate giving 
is one that creates value for beneficiaries while enhancing the performance of the core 
business. In other words, giving must be mutually beneficial to be sustainable. Bruch and 
Walter (2005) marry many of the scholarly ideas in previous literature to discuss the market 
and competence orientations of corporate giving. A market orientation is giving that caters to 
stakeholder needs, while a competence orientation is giving that focuses on a corporation’s 
core business. Companies who only cater to stakeholder pressures (and thus ignore their core 
business) take a peripheral approach to giving. A constricted approach focuses giving and 
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other CSR activities solely on the competencies of the core business and ignores the needs of 
stakeholders. A dispersed approach is a haphazard approach to giving devoid of any 
strategy—either for stakeholders or the core business. Finally, Bruch and Walter (2005) 
describe the strategic approach: stakeholder needs are evaluated and met while maintaining a 
focus on the core competencies of the business. This strategic approach, they argue, is the 
only sustainable form of strategic giving.  
As shown here, scholars debate the strategy behind corporate giving. Recently, 
however, the literature has moved to discuss a more singular motivation for corporate giving: 
stakeholder management. Brammer and Millington (2004) found that the level of stakeholder 
pressure on an organization determines how corporate giving is managed. The more pressure, 
the more likely corporate giving is managed by an outward facing function such as marketing 
or public relations. In fact, the researchers found that those organizations with the most 
stakeholder pressure are significantly more likely to delegate corporate giving decisions to 
the marketing department, which is expected to make those decisions in ways that enhance 
the core business while satiating the interests of stakeholders.  
Campbell and Slack (2006) found a positive relationship between public visibility and 
corporate giving. High public visibility companies—such as pharmaceutical companies or 
highly branded consumer goods companies—have more intense pressure from stakeholders. 
These companies are more likely to use corporate giving as a strategic tool to manage 
stakeholder pressure.  
Saiia, Carroll, and Buchholtz (2003) discussed the same concept, but referred to it as 
business exposure. The more a business is exposed to the public, the more intense the 
pressure is from stakeholders, and corporate giving can be used to manage these 
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stakeholders. In addition to citing the importance of stakeholders, Saiia et al. (2003) married 
in Bruch and Walter’s (2005) concept of ensuring that corporate giving is related to the core 
business while it caters to stakeholders: charity begins at home. “Corporations can contribute 
to their communities in more meaningful and effective ways by carefully defining what they 
stand for as corporate organizations” (Saiia et al., 2003, p. 170). 
Saiia et al. (2003) also found that giving is becoming more strategic because of the 
professionalism brought to its practice. Market pressures force companies to be strategic 
about their business, and the same goes for corporate giving. The corporate giving managers 
themselves (or the manager to whom corporate giving decisions are delegated) want to make 
strategic decisions for their companies. Their own careers are on the line, and the more they 
can do to be strategic in their decisions, the more personal gain they may achieve.  
Finally, corporations recognize the strategic value corporate giving can provide, and 
now they are expecting it to continue to provide value (Saiia et al., 2003). Corporate giving 
has the ability, if managed strategically, to improve stakeholder relationships and enhance the 
core business of a company (Bruch & Walter, 2005). This thesis seeks to pursue this current 
direction of scholarship. 
This section discussed corporate giving and strategic giving and how those concepts 
are related to corporate social responsibility. The next section will discuss specific forms of 
corporate and strategic giving to illustrate exactly how a company might go about its giving 
activities. 
Forms of Corporate and Strategic Giving 
Forms of corporate giving include social venture giving, employee giving, surplus 
inventory gifts, in-kind donations, and cause-related marketing (Heath & Vazquez, 2001).  
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Employee volunteerism is also an important part of corporate giving, whether general 
volunteer work or the donation of employee talents to nonprofits in need of expertise, it 
benefits the community and often improves internal employee morale. For example, a 
healthcare marketing executive might offer to develop a marketing plan for a local nonprofit 
clinic.  
 Cause-related marketing is another important aspect of CSR. It is typically a short-
term strategy connecting the marketing of a product with a certain social cause. For each sale 
of the product, a certain percentage of the sale is given to that social cause (O’Connell, 
2004). The campaign that essentially defined cause-related marketing was the American 
Express campaign: for every dollar charged on the American Express credit card, one cent 
was donated to restoring the Statue of Liberty. The number of cardholders surged, American 
Express received positive press, consumers felt good about doing business with the company, 
and an American icon was restored (Welsh, 1999).  Cause-related marketing is almost always 
beneficial to the corporation and the cause, but not always the consumer. Pracejus, Olsen, 
and Brown (2003) found that most cause-related marketing offers vague benefits without 
specifying the commitment to the cause. Dean (2003) found that unconditional giving, rather 
than cause-related marketing, is more closely tied to positive consumer perceptions of a 
company. In spite of this debate, cause-related marketing is a popular form of strategic giving 
for many corporations.  
 All of the forms of discretionary CSR discussed, including employee volunteerism, 
in-kind donations, and cause-related marketing can be considered corporate giving. They can 
also be considered strategic giving, depending, of course, on whether a strategic business 
objective motivates the giving. 
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This section explained forms of corporate and strategic giving. The next section will 
provide a summary of the literature reviewed for this thesis. 
Summary of the Literature 
While the body of CSR literature continues to grow, the voices of the past—including 
Friedman (1970) and Carroll (1979) —continue to be incorporated into new theory and 
perspectives. For many, the jury is still out as debates surround the fundamental 
responsibility of corporations, ways to define CSR, the investment potential of its practice, 
and strategic giving. Stakeholder theory is an important theory in understanding CSR. It 
requires a corporation to pay attention to and balance the legitimate interests of all 
stakeholders, recognizing their power and stake in the corporation (Freeman, 1984). 
Theoretical development in CSR continues, and many scholars are looking at its connection 
to corporate outcomes and bottom line performance (Burke & Logsdon, 1996). The review of 
the literature traced the development of theory in CSR, explained the conceptual framework 
of stakeholder theory specifically, and explored the meaning of corporate and strategic 
giving. The next section will pose the research questions for this study.  
Corporate Giving at Healthcare Corporations 
The literature is both broad and deep on the theory and practice of CSR. The literature 
reviewed for this study, however, does not address executive perceptions of corporate giving, 
specifically at healthcare corporations. This perception is important because there must be 
executive support for CSR programs to receive the attention necessary to thrive and benefit a 
corporation (Heath & Vasquez, 2001). The literature also has not addressed executive 
perceptions in the niche of healthcare companies and their corporate giving. Healthcare 
corporations are of particular importance as the industry is often maligned with harsh public 
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perceptions and a strict regulatory environment. These corporations, however, also have the 
profit and products to be able to contribute to society in a meaningful way while strategically 
enhancing their core business.  
Research Questions 
This study will address the following research questions in an effort to understand 
executive perceptions of CSR and corporate giving in the context of healthcare companies: 
1.  To what extent do executives at healthcare corporations view corporate giving 
as a means to achieve strategic business objectives?   
2.  To what extent do executives of healthcare corporations perceive corporate 
giving as a part of their organization’s CSR commitment?  
 
CHAPTER III 
METHOD 
 
This thesis uses qualitative research to explore the questions posed in the previous 
section. The following section will justify the use of a qualitative method, specifically in-
depth interviews. I will also explain my method of data collection and analysis for the study. 
Finally, I will describe how I identified participants, reflexivity issues I faced, and approval 
from the Institutional Review Board.  
Qualitative Research 
Qualitative research emphasizes the socially constructed nature of reality.  Using 
qualitative research, we study how meaning is created, while quantitative research 
emphasizes analysis of causal relationships (Denzin & Lincoln, 2000). This thesis explores 
how executives perceive the strategic value of giving at their corporations. I want the 
executives to give meaning to their corporation’s giving practices by explaining what those 
practices mean to them. Therefore, using a qualitative approach will likely provide richer 
data for analysis than a quantitative method would provide. The following sections will 
further explore the appropriateness of qualitative research for my study.  
In-depth Interviews 
To understand the perceptions of the healthcare executives, I conducted in-depth 
interviews with the participants. The in-depth interview is a popular qualitative research 
method that uses open-ended questions to allow for a greater breadth of data to emerge from 
the participants. In-depth interviews are a valuable research tool in attempting to understand 
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participants without imposing categories or labels that would limit the scope of inquiry 
(Fontana & Frey, 2000).  
In-depth interviews yield the richest and greatest breadth of data of any method. The 
data have the vividness of words, stories, and experiences of participants in their own words. 
The vivid quality of the data can be more convincing and meaningful to a reader than pages 
of numbers (Fontana & Frey, 2000). Also, when studying a subject about which little is 
known, in-depth interviews can be a helpful tool. Information can be culled from participants 
to help illuminate and bring understanding to a new subject. Interviews can also yield new 
insights that were not present in prior theory development or research. Open-ended questions 
allow for a variety of responses that surveys or other methods cannot access (Denzin & 
Lincoln, 2003). Participant responses during in-depth interviews are the direct words of the 
participants. Rather than the researcher imposing a vocabulary or categorization of topics 
onto the participants’ words, the participants are free to define, identify, and explain, topics 
from their own perspectives (Fontana & Frey, 2000).   
The researcher is the instrument when conducting in-depth interviews. As a human 
instrument, the researcher has flexibility: entirely new questions may be asked if appropriate 
or respondents may be probed for more detailed responses. A researcher can spend more time 
on parts of the topic that excite the participant and yield particularly interesting data. The 
researcher can also garner feedback from the participant. The flexibility of in-depth 
interviews also allows researchers to develop rapport with the participant and extract more 
sensitive information than a survey. Since meaning is created through interaction, in-depth 
interviews can provide insights that other methods cannot (Fontana & Frey, 2000). 
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As with any method, in-depth interviews present a set of challenges. Pursuing such 
rich data is exceptionally demanding, laborious, and costly. The thoughtful analysis of 
interview transcripts is time-intensive. Even a team of researchers working on a large study 
can only handle a few dozen interviews before the amount of data may become too much to 
thoughtfully analyze. Therefore, the generalizability of qualitative data from in-depth 
interviews is low if not nonexistent (Fontana & Frey, 2000). In addition, there is no fool-
proof method for analyzing the data. Any given researcher may come to a different 
conclusion. It is difficult—if not impossible—to replicate a qualitative study using in-depth 
interviews. Finally, while the vividness of words, experiences, and stories from the 
participants makes the data particularly rich, words are inherently ambiguous and carry 
different meanings for different people (Fontana & Frey, 2000). 
The interviews are guided by questions (see Appendix I for the interview guide) but 
the interview is conversational in nature, and participants may bring up topics throughout the 
interview as they feel comfortable in discussing them. The participant may also bring up 
topics that were not anticipated by the interview guide. McCracken (1988) refers to this 
nature of qualitative, in-depth interviews as “extemporaneous strategies of investigation” (p. 
9). The open-ended questions and nature of the in-depth interview allow participants to fully 
explore and explain their perceptions of corporate giving.  
It is important for researchers to understand the language of the participants, decide 
how to present oneself, gain trust, and establish rapport with participants (Fontana & Frey, 
2000). After spending more than three years working in the corporate healthcare industry, I 
enjoyed a high comfort level in understanding the language of the executives. In addition to 
conducting extensive background research on each corporation before each interview, I 
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explained my past work in the healthcare industry and my academic pursuits to help gain the 
trust of participants and to establish rapport with them.  
Data Collection 
During January and February 2006, I conducted 11 in-depth with healthcare 
executives at seven different companies: one U.S.-based biotechnology firm, one U.S.-based 
global medical technology company, three U.S.-based global pharmaceutical companies, one 
Swiss-based global pharmaceutical company, and one U.K.-based global pharmaceutical 
company.  The interviews lasted from 45 to 80 minutes, depending on the time constraints of 
the participants.  Most in-depth interviews are at least 45 minutes in length, and can last for 
hours (McCracken, 1988). I conducted interviews with ten participants at their respective 
office sites; I conducted one interview in a hotel lobby during a conference the participant 
attended. My goal in setting a time and location for the interviews was the comfort and 
convenience for the participants. Each participant signed a consent form prior to the 
interview (see Appendix II for the consent form). 
With the consent of each participant, I recorded the interviews on a digital recording 
device. A verbatim account of the interview is essential, and a recording device allowed me 
to take other notes during the interview. It also allowed me to pay more attention to the 
participant and to ensure the conversational integrity of the interview (Fontana & Frey, 
2000). I employed the services of Franklin Square Transcriptions in Chapel Hill, NC, to 
transcribe each interview. 
Participants 
 In qualitative research, selecting the participants is a crucial step to ensure the quality 
of research. As discussed in the previous section, I recruited 11 participants for the 
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interviews. Because the focus of the study is executive perceptions of corporate giving, I  
interviewed high-level employees at healthcare corporations, specifically, one president, 
three senior vice presidents, four vice presidents, one senior director, and two directors. The 
responsibilities of the participants included planning, contracting, business development, 
compliance, media relations, research and development, corporate affairs, sales and 
marketing, commercial operations, and government reimbursement and policy. Seven 
participants were men and four were women. In seeking participants with senior positions 
and at least five years in the healthcare industry, I was able to interview participants with a 
rich knowledge of corporate strategy and goals, and at least some knowledge of corporate 
giving initiatives. Due to the purpose of this study to understand perceptions of executives 
throughout a company, I did not interview executives whose core job responsibility was 
corporate giving or corporate social responsibility.   
 I conducted one pilot interview with a healthcare executive to identify potential 
problems (Fontana & Frey, 2000).  The pilot interview indicated the questions were 
appropriate, and I did not change the interview guide prior to beginning research with the 
participants. I did not use information gathered from the pilot interview in this research.  
To recruit participants for the interviews, I used snowball sampling to identify willing 
individuals. I used contacts from my previous industry experience, as well as contacts 
through friends and professors. I emailed potential participants in January 2006 to schedule 
interviews (see Appendix III for recruiting letter). After following up by phone with each 
participant, I scheduled interviews to take place in January and February 2006. The following 
table presents the participants, their titles, and company descriptions. In the next section, the 
method of data analysis from these interviews will be discussed.  
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Table 1. Participant chart. 
Pseudonym Title Company description
Karl VP, Planning & Contracting Swiss-based global pharma 
Ben Director, Media Relations U.S.-based global pharma 
Catherine SVP, Chief Compliance Officer U.K.-based global specialty pharma  
Danica Director, Media Relations U.S.-based global pharma 
Daniel VP, Business Development U.S.-based mid-size pharma 
Doug SVP, Research & Development U.S.-based biotech  
Garrett SVP, Sales & Marketing U.S.-based biotech  
John President U.S.-based global medical technology 
Linda VP, Global Corporate Affairs U.S.-based biotech 
Sally VP, Commercial Operations U.S.-based biotech  
Sam Senior Director, Government 
Reimbursement & Policy 
U.S.-based global pharma 
 
Data Analysis 
 As mentioned, I hired Franklin Square Transcription in Chapel Hill, NC, to transcribe 
the interviews. To analyze the data, I followed the analytic procedures as outlined by Miles 
and Huberman (1994) and their three streams of concurrent data analysis: data reduction, 
data display, and conclusion drawing/verification.  
 Data reduction is the process of analysis consisting of focusing and simplifying the 
data from the interviews. Summarizing parts of the data, clustering it into meaningful sub-
parts, and looking for emerging themes are all part of the data reduction stream of analysis. 
This process helps to sharpen, focus, and analyze data in ways that help final conclusions to 
be drawn.  
At this point in the process, I began to code my data, again following the 
recommendations of Miles and Huberman (1994). Codes are essentially categories that 
cluster the data and prepare it for analysis. I categorized codes into emic and etic groups. 
Emic codes reflect the perspective of my research participants—they are the ideas and 
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responses to interview questions as expressed in their own terms. Etic codes are my 
interpretation of the data—they are the extrinsic codes expressed in the terms of the 
researcher. Etic codes are essential for comparison of the data across participants. Most 
importantly, the etic codes are informed by the emic codes. This analysis allowed me to look 
at the data in terms of the participants while also applying my own interpretation based on 
the theoretical framework set forth in this study.   
To begin the coding process, I read through the interview transcriptions at least three 
times per each transcription. As I read through the transcription, I would make notes as to the 
emic codes that emerged. During this process, I also made notes as to the data that fit with 
each code. While a code may emerge from one interview, it was often repeated in other 
interviews. After reading through all 11 interviews, 24 total emic codes emerged. I then made 
a map of how the emic codes fit together, again based on how the data supported each code. 
These codes are listed and mapped in the next chapter.  
 The next stream of data analysis is data display (Miles & Huberman, 1994). Data 
display is an organized way of capturing a large amount of data into an easily understood 
summary of information. Data display may include matrices, graphs, charts, figures, and 
other tools to help organize data into an easily accessible form. These visual displays of the 
data may prepare data for final analysis, or they may show gaps in the analysis that will 
require me to revisit the coding process. These are concurrent streams of analysis, so coding 
will continue even when data display or conclusion drawing is also happening.  
 Conclusion drawing and verification is the third stream of analysis of qualitative data 
(Miles & Huberman, 1994). During this process, I interpreted the meaning of the data by 
noting themes, patterns, explanations, and propositions. The first step is to note patterns and 
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themes, which I did when deciphering the etic codes; the final step is to make conceptual and 
theoretical coherence. These conclusions are verified as analysis of the data continues by 
going back to the data itself, and back to the research participants if necessary.  
 As I went through the processes of data reduction and data display, I began to draw 
conclusions based on my interpretation of how the data supported the etic codes. As I 
continued to read through the data and put it into the tables based on which code I felt it 
belonged to, I made notes as to what I felt was the most important data, how strongly the data 
supported the etic codes, and how the meaning of the data related to literature I reviewed. In 
drawing these conclusions, I continually revisited the transcripts to ensure that I was using 
data in right context and not twisting the words of participants simply to fit into certain 
categories. Throughout the process, I revisited the full transcripts to ensure I used the 
language of the participants as often as possible, and to ensure that I continually used their 
explanations and descriptions of topics rather than rephrasing those topics in my own words. 
My goal was to make certain that the voices of the participants took precedence over my own 
voice.  
 Using Miles and Huberman’s (1994) three concurrent streams of data analysis, I took 
my data from its initial collection to final conclusions. The following section will discuss the 
reflexivity issues I encountered during the research.   
Reflexivity 
Reflexivity is the personal involvement of the researcher in the topic, and it is 
important for a researcher to reflect on being his or her own research instrument. Discussing 
reflexivity issues helps to explain the personal investment of the researchers, biases brought 
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to the research, and ways in which researchers avoid or emphasize certain points of view 
(Gergen & Gergen, 2000).  
One bias I bring to this thesis is my work with healthcare companies in the past. I 
believe they are better corporate citizens than the general public perceives them to be, but I 
also feel they should be doing more when it comes to corporate giving. I also believe these 
corporations have a responsibility to be strategic in their giving to ensure that stakeholders’ 
interests—including shareholders—are served.  
Another bias I bring to the research is my knowledge of CSR and corporate giving 
acquired during the preliminary reading for this thesis. In making maps (data display) of how 
I see relationships among the data, I may be imposing my knowledge of how I think it should 
be, rather than how the participants explained it to me. At all times I attempted to use the 
language of the participants and allow their voices to be dominant, but I did bring a bias to 
the research in having a preconceived view of how I think CSR and corporate giving is 
practiced. 
The issue of voice in qualitative research is critical. I took an interpretive approach to 
the research, wanting more to understand how the participants create meaning about CSR and 
corporate giving rather than force my views of CSR and corporate giving onto my 
participants. I cannot presume that my own meanings are the same as my participants’ 
meanings; however, I inevitably imposed my own meanings on their language simply by 
conducting my data analysis.  
Reality is subjective from my interpretive approach. Nothing about the research is 
inherently true—it is subject to the interpretation of others. Through self-reflexivity and thick 
description using the language of the participants, I attempted to establish the authenticity of 
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the research. In the end, I share the privileged voice in this research with my participants: in 
this thesis, my own voice is dominant at times, such as in my discussion, and at other times 
the participants’ voices are dominant, such as in the findings.  
Interpretive qualitative research is subjective, and in this section, I have described 
some of the biases I brought to the research and reflected on myself as the instrument of 
research.  
Institutional Review Board 
 The study received expedited review from the IRB, as the interview participants are 
not members of a vulnerable population and the data sought are not sensitive or confidential 
in nature. The IRB approved the study on January 5, 2006.  
Summary of Methods 
 This section provided an explanation of qualitative research and in-depth interviews. 
It also explained how I collected and analyzed the data, and how the participants were 
identified. Finally, I discussed issues of reflexivity in this study and the Institutional Review 
Board. In the following chapter, I will present the findings of the research.  
CHAPTER IV 
FINDINGS 
 
Through eleven interviews with healthcare executives, several themes began to 
emerge from their perceptions of CSR and corporate giving at their organizations. In this 
chapter, these findings are presented using the voices of the participants to illuminate the 
perceptions of healthcare executives. Some findings are more evident than others in that 
more participants spent time explaining their thoughts in specific areas. The findings are 
concentrated around the topic of corporate giving, though findings also emerged related to 
the general practice of CSR. Most importantly, executives agree that there is often a strategic 
business objective to corporate giving, and they perceive corporate giving to be a component 
of the CSR commitment of the organization.  
Emic Codes 
As described in the previous chapter, emic codes emerged from the participant 
responses. As a first level of data analysis, 24 emic codes emerged regarding executives’ 
perceptions of CSR and corporate giving, and I mapped these codes as displayed in Figure 1 
to help visualize how the codes connected to each other.  
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Once I had 24 emic codes, I went back through each transcription and copied the data 
matching to each code into a table representing all the data that fit with that code. I therefore 
had 24 tables, organized by participant, with all of their quotes that fit with that particular 
code.  
These emic codes are the main themes that emerged from in-depth interviews with 
participants. As is depicted, the major themes included the mission and values of the 
company, the culture, the notion of staying within the industry to build partnerships and 
make an impact, relationship building, the reality of market pressures, and the agreement that 
CSR is becoming more strategic. These major themes are connected in a somewhat linear 
fashion in that the mission, values, and culture of an organization form a foundation to 
Mission/values
Culture
Big/small company
Support of leadership
Employee relations
Community relations
Corporate citizenship
Ethical business commitment
Healthcare attracts special people
Market pressure
Basic strategy
Start with the issues 
Where decisions are made
Give like people give
Negative impacts
Image
Industry-partner-impact 
Relationships 
Sales 
Stakeholders
Indirect influence
Competitive advantage
Becoming more 
strategic 
Figure 1. Emic codes.
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support corporate giving functions (including giving within the industry and giving to bolster 
employee and community relations), which in turn helps a company build relationships with 
stakeholders, and finally move towards a more strategic approach to CSR.  
Several subthemes support the major emic codes. For example, employee and 
community relations are related to corporate citizenship, which is a component of an 
organization’s culture. Basic strategy and decision-making for corporate giving is related to 
how an organization approaches giving within the industry to build partnerships and make an 
impact. Finally, sales, competitive advantage, and stakeholder management are some of the 
subthemes that support the major theme of relationship building.  
These emic codes represent how participants talked about CSR and corporate giving. 
As I discuss in the next section, I collapsed these codes to form etic codes that allowed me to 
make more comparisons between participants and look more closely at the relationships 
between the major themes that emerged in the research.  
Etic Codes 
After sorting through my data and its relationship to the emic codes, I studied the 
resulting data tables, reading through each table several times. At this point, I began to sketch 
the etic codes that represented my interpretation of the data. As suggested by Miles and 
Huberman (1994), I made reflective remarks during the coding process, which are 
observational notes I wrote while reading through the data.  I also made marginal remarks 
while coding—these remarks are more analytical in nature and served as clues for how the 
data come together to form meanings. These notes eventually helped me to form the etic 
codes by which I interpreted the data. At the end of the data reduction process, I had seven 
etic codes through which I interpreted the data. Figure 2 represents these etic codes and the 
39 
 
interconnectedness between them based on my interpretation of the data. Developing the etic 
codes allowed me to make comparisons among the data. 
Figure 2. Corporate giving process model. 
 
The tables I made to capture data into the emic codes are a form of data display, as 
are Figures 1 and 2. I also made tables based on etic codes, and listed quotes from each 
participant that supported the etic code. Another table I used for data display can be found in 
Appendix IV, which charts the strength of the findings for each participant.  
These forms of data display allowed me to better understand the data and interpret its 
meaning. As previously mentioned, data reduction and display are concurrent processes, and 
I continued to go back and code data as I made displays to help interpret its meaning. I also 
began drawing conclusions during these processes. 
Findings Overview 
The most important themes emerging from the research and how those themes are 
interconnected are described above in Figure 2 and then explained in more detail throughout 
the chapter. A brief explanation of the figure is offered here.   
1-Foundation of 
organization 
mission and culture
3a-Employee/ 
Community 
relations
3b-Core business  
corporate giving
4-CSR philosophy 6-Becoming more strategic
5-Market pressure
2-Leadership 
Support 
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The figure is labeled as a process model of corporate giving. As evidenced in the 
emic codes from which this process model developed, participants described corporate giving 
and CSR in a linear fashion. This linear description lends itself to the notion of an actual 
process a company might go through to think about its approach to corporate giving, and in 
turn, its approach to CSR in general. I offer the following description of the corporate giving 
process to illustrate the relationships depicted in Figure 2.  
As participants discussed their perceptions of CSR and corporate giving, it became 
clear that the mission and culture of the organization formed the basis for how the company 
approached its CSR and corporate giving initiatives (1). Participants also perceived 
leadership support to be a key component of reinforcing the mission of the company and 
sustaining the culture of the organization (2). An important relationship emerged between 
strong leadership support and a strong mission and culture of an organization. The first part 
of the corporate giving process model depicts the necessity of leadership support to reinforce 
a company’s mission and culture. 
It also became clear that the mission and culture of the organization (reinforced by 
leadership) set up two different ways in which companies approached CSR and corporate 
giving. The first approach (3a) relates to how companies use CSR and corporate giving to 
improve employee and community relations. The second approach (3b) relates to how 
companies use CSR and corporate giving to enhance their core business. All participants said 
that their companies take both approaches to corporate giving: some giving resources are put 
towards the first approach of improving employee and community relations, while other 
resources are used to bolster the core business of the company. The corporate giving process 
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model shows that both of these approaches are functions of the mission and culture of the 
organization.  
The next part of the process model shows that both approaches to corporate giving, as 
well as the mission and culture of the organization, define part of the organization’s overall 
CSR philosophy (4). The overall CSR philosophy also includes the participants’ perceptions 
of the ethical business commitment of their companies and the general social responsibility 
expected of the organizations. Because this is a corporate giving process model, those other 
dimensions of CSR are subsumed under the general CSR philosophy rather than being 
explicitly depicted.  
The general CSR philosophy—which is in part defined by the two approaches to 
corporate giving and the mission and culture of the organization—is greatly affected by the 
market pressures (5) bearing on the company.  Market pressures include the expectation from 
shareholders that a company think strategically about every dollar it spends; market pressures 
also include the state of the industry, current economic conditions, and myriad other factors 
that comprise the market conditions under which the company operates.  
After going through this process—from a foundation of mission and culture, through 
two approaches to corporate giving that partly define the overall CSR philosophy of a 
company, and finally realizing the market pressures that force reality upon a company, we 
come to the end of the process. The model depicts the participants’ perception that their 
companies’ approach to CSR is becoming more strategic over time (6). As described in the 
following findings, it is becoming more strategic because of the realization that corporate 
giving can be a strategic tool for a company to improve employee and community relations 
and bolster the core business of the company. The realization of the strategy behind this 
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process—and the subsequent realization of the benefits it can provide the company—move 
the companies into a more strategic realm of corporate giving. As they move through this 
process, they become more strategic because they realize the benefits of being strategic. It is 
a linear process, but it is one that continually cycles through itself. In becoming more 
strategic, the process feeds back into the corporate giving decisions related to employee and 
community relations, and core business corporate giving.  
This section provided a summary of the findings as depicted in the corporate giving 
process model. The following sections will present the findings in more depth. In the final 
chapter, the implications and meanings of these findings will be discussed. 
Foundation of mission and culture 
 
The mission and culture of the organization provide a basis from which to approach 
CSR and corporate giving. Seven of the participants discussed the mission of their 
organizations and how it relates to corporate giving and CSR. They explained that in tough 
situations, where difficult decisions have to be made, keeping the company’s mission in mind 
helps to guide decision-making.  
 John, president of a U.S.-based global medical technology company, said a simply 
stated mission helped all employees think quickly about whether or not a giving initiative 
would be appropriate for the company. If the initiative helped people live healthy lives, then 
it was adequately aligned with the mission and therefore appropriate. “A company has to be 
very clear on what its purpose is, and if it does a good job defining its purpose, it will help 
you manage virtually any and all activities that you happen to be pursuing... It’s so simple.” 
 Catherine, Senior Vice President and Chief Compliance Officer of a UK-based global 
specialty pharmaceutical company said giving must be connected to the mission.  
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Maybe we could go plant trees on a local soccer field or something. But 
is that really connected to what [our company] is about? Let’s come up with a 
framework of how we’re going to think about giving, so we’re not just kind of 
flying around throwing little bits of money at little projects that are maybe not 
completely meaningful to the people who get them. 
 
Danica, Director of Media Relations for a U.S.-based global pharmaceutical 
company, said that giving to healthcare causes speaks to who the company is at the core. 
“We are a global healthcare company. Public health is—it’s our mission.” Garrett, Senior 
Vice President of Sales and Marketing for a U.S.-based biotechnology company said his 
company believes in adhering to its values because they are “the glue, the fabric that holds 
companies together in tough times.” He said those same values help drive corporate giving. 
Other participants echoed these sentiments of relying on the mission of the company to guide 
business decisions, including those about corporate giving and CSR.  
 Participants also talked at length about the importance of corporate culture guiding 
the business itself, and in particular their stance towards CSR and corporate giving. Stories 
about employees volunteering in Hurricane Katrina relief efforts or volunteering their time at 
clinics in Africa built a narrative within the companies that supported the organization’s 
culture and helped link the culture to the company’s mission of providing healthcare—not 
just with commercial products, but also through CSR.    
Three participants—two from the two smallest companies and one from the largest 
company included in the research—cited the values of the company’s founder as a driving 
force of the organization’s culture. Part of the founder’s philosophy explicitly included 
giving back to society, and the mission to give remains ingrained in the culture of the 
company. Referring to the founder, Daniel, Vice President of Business Development for a 
U.S.-based mid-size pharmaceutical company said, “She [the founder] is someone who, just 
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by her character, her integrity, the way she lives her lifestyle, she is just a very generous 
person. So this company has kind of been formed in her own image.”  
 John’s company sent 10 employee volunteers to Africa to work at an HIV clinic for 
10 days. The employees communicated the poor conditions of the clinic, and the company 
donated more supplies and financial support. “The whole place was energized by this.” The 
employee volunteers came back and gave a presentation with pictures from their work in 
Africa. “This little momentum…builds. There is something exciting about communication 
and awareness of what’s going on. Everybody in this company who’s ever got on our website 
knows we did this.”  
 This section discussed how the mission and culture of an organization provide a 
foundation on which approaches to CSR and corporate giving are often based. The following 
section will discuss the importance of leadership support for this foundation.  
Leadership Support 
 
Leadership support for the organization’s mission and culture emerged as an 
important theme during the research. Eight of the participants discussed the reinforcement of 
mission and culture provided by the leadership of the company. They said the support of 
leadership helped instill the spirit of giving back throughout the company. Ben, Senior 
Director of Media Relations for a U.S.-based global pharmaceutical company, talked about 
the importance of the CEO’s role in being “directly involved” in giving initiatives. Danica, 
Director of Media Relations for the same company, said, “Things happened [giving efforts] 
because there is a commitment, and that commitment starts at the top.” In reference to the 
company’s Hurricane Katrina efforts, she said the CEO “picks up the phone himself, makes 
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calls as we’re working through the reconstruction on the ground there, reaching out to other 
companies…it comes from the top.” 
 Garrett, Senior Vice President of Sales and Marketing for a U.S.-based biotechnology 
company, explained the importance of leadership respecting the days the company set aside 
for employees to do community service projects. 
Senior management is expected to be visible, by company meetings and 
rolling up their sleeves and walking the talk. If we are going to have a work day, 
we are expected to be out there. Two things: we are supposed to be out there 
helping; we are also not to be scheduling important meetings on those days so 
we don’t give our employees a mixed message. Okay, so the words to the music 
have to match. 
 
Sally, Vice President of Commercial Operations, at the same biotech company, said a 
commitment to CSR and corporate giving is “driven from the top.”  
With a general agreement that support for the mission and culture comes from the 
leadership of the organization, participants discussed the different ways in which decisions 
are made regarding CSR initiatives, including corporate giving, and how that is related to 
leadership support of CSR generally.  
 The eleven participants in this research represented seven companies. Out of those 
seven companies, five have departments designated to make corporate giving decisions, and 
two have cross-departmental committees set up to make these decisions. John, President of a 
U.S.-based global medical technology company explained that while “senior managers are in 
no way disengaged,” no senior managers sit on the committee that recommends giving 
initiatives for the company. The CEO ultimately makes the final decision whether to give or 
not, but “It used to be kind of a top-down thing, in other words so-and-so is on the symphony 
so let’s give money to the symphony. We don’t want the top-down self interest thing in any 
way to be superimposed on the direction that the organization takes.” Participants whose 
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companies had a department in charge of corporate giving decisions said it helped decisions 
to be more centralized. All participants indicated that big giving decisions ultimately needed 
leadership approval.   
 This section discussed the importance of leadership support for the organization’s 
mission and culture to thrive. The following section discusses the first of two approaches to 
CSR and corporate giving as they emerged from the research. The first approach relates to 
employee and community relations.  
Employee and Community Relations 
Executives discussed the strategy behind corporate giving and CSR in two ways: the 
strategic importance of enhancing relationships with employees and the community, and the 
strategic importance of using corporate giving to bolster the core business. In this section, I 
will present the findings of the first approach: employee and community relations.  
Healthcare attracts special employees. To begin, nine of the eleven participants 
talked specifically about how healthcare companies attract special employees: people who 
work in healthcare have a proclivity for helping society. “A lot of people who work at 
pharmaceutical companies come here because they feel like they are doing something good. 
They are curing disease or extending life, and that makes them happy to come into work each 
day, as opposed to coming in and making widgets.” (Karl, Vice President of Planning and 
Contracting). “They could be out there making widgets or selling shoes, but they chose to be 
in the pharma industry for a reason” (Daniel, Vice President of Business Development). 
Therefore, healthcare companies must engage in CSR and corporate giving because 
employees expect it. “I think people expect you to be giving. Employees do” (Catherine). 
Employees want to feel good about their company. “Their individual souls are such that they 
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would want to work for a company that had a responsible corporate giving program” 
(Daniel). Linda, Vice President of Global Corporate Affairs, agreed. “I think it attracts a 
certain kind of individual who’s into betterment for the greater good of others. And I think 
that’s why there’s this commonality among our employees that is so nicely married with 
social responsibility, giving back, because that’s what we want to do.”  
Employee Relations. The importance of good employee relations quickly became 
evident: every participant spent a great deal of time discussing the topic. In particular, all 
eleven participants acknowledged improved employee relations as a strategic benefit of the 
organization’s engagement in CSR and corporate giving. John (President) talked about the 
energy it creates within the company, referring to it as “employee engagement.” His 
company sent 10 employees to Africa to work at an HIV clinic. 
People get a charge out of this! They feel good about it! They packed the 
auditorium when they came back from Zambia. There are 300 and some seats 
down there and you couldn’t get in there. People were standing in the back. 
They wanted to hear about this. When I go down to do my business update, I’m 
lucky if I can get 200 people. It’s just a fact. It’s not a criticism but it just shows 
you what engages people. You know the average person who comes to work 
here doesn’t care about my earnings last quarter. They care about that in the 
context did we do some other things with that, and boy they get excited about it. 
So I think it’s the thing that we are really trying to build around here. 
 
Daniel expressed a similar sentiment—making employees feel good is a benefit of corporate 
giving.  
People want to feel good. Our CEO, our new CEO, when he had his 
kickoff meeting said, “I want this to be the kind of place that people skip to 
work.” He was being a little silly, but I think the idea is, I want to feel good 
about coming here… So I think we do want people to feel good about working 
here; and that’s one of the reasons that we do some of the things, I’m sure, we 
do from a corporate giving standpoint. 
 
According to all participants, employee morale is an important motivation to engage 
in CSR. “We use it as a morale booster and a rallying point for our employees… Employee 
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morale, it’s terrific. And you get to go to bed at the end of the night and know that you’ve 
done the right thing” (Linda, VP, Global Corporate Affairs). 
 One participant, Sam, Senior Director of Government Reimbursement and Policy 
from a U.S.-based global pharmaceutical company, said that not only does corporate giving 
help employees feel good about the company, but it creates an opportunity for employees to 
carry out public relations for the company. “We feel that our best resource for public 
relations is our own employees so that people see what we’re doing in the communities.”  
 Employee volunteer time is also celebrated by all of the companies involved in the 
research. Danica’s company is sending her to work for three months at the World Health 
Organization, donating her time and talents for World Health Day. The company will 
continue to pay her salary and cover travel expenses. At John’s company, where they sent 10 
employees to work at the African AIDS clinic, he said almost 400 employees applied for the 
10 spots to go to Africa next year. 
 Participants felt strongly that engagement in CSR and corporate giving improved 
relations between the organization and its employees. Participants also perceived CSR and 
corporate giving to improve an organization’s community relations. The next section will 
discuss this perception.  
 Community Relations. In addition to improving employee relations through corporate 
giving and CSR initiatives, companies also look to improve relations with the communities in 
which they operate. All eleven participants cited improved community relations as a benefit 
of CSR and giving initiatives.   
There is a—just a general philosophy that if you’re a large and 
successful company you should have programs that give something back to 
communities. There is a publicity aspect to it. I mean, there’s a selfish aspect to 
it in that we do try to get recognized for some of it because we think that that 
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sends a positive message to the communities where we operate, as well as to our 
employees. (Ben, Senior Director, Media Relations) 
 
All the companies engaged in local giving programs, and all related to the image the 
company garnered in the community. “Things we do locally are more to have a positive 
image within the communities that we work and live in” (Daniel, VP, Business 
Development).  
Participants also talked about supporting the community that supports their business. 
Ben, Senior Director of Media Relations, explained: 
You operate at the will of the communities you live and work in and part 
of, I think, most companies in the United States, certainly most large 
companies, feel that they have to just as a part of their…ability to operate, they 
have to give something back to the communities in which they reside or serve. 
 
Supporting communities is also important because “it’s good to be a good neighbor” 
(Catherine, SVP and Chief Compliance Officer).  
 Having established improved employee and community relations as a perceived 
strategic benefit of CSR and corporate giving, I now consider the second approach to CSR 
and corporate giving as it emerged during the research. This relates the use of CSR and 
corporate giving to enhance the core business of the companies.  
Core Business Corporate Giving 
Participants discussed several ways in which corporate giving specifically benefits the 
core business. Findings presented in the following sections—as related to core business 
corporate giving—include the motivations behind corporate giving and why giving within 
the healthcare industry provides strategic benefits for healthcare companies. Findings 
encompass the cycle of opportunity that occurs when companies give within their industry, 
build partnerships and make an impact through corporate giving. The gains and benefits of 
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corporate giving are also presented, including competitive advantage, indirect influence of 
stakeholders, relationship building, the effect on sales, and corporate image. Finally, I present 
findings about basic corporate giving strategy and the possibility of negative attention 
resulting from corporate giving initiatives.  
Motivation. To begin, executives discussed the motivations behind corporate giving 
programs. All participants agreed that corporate giving often has a strategic business 
objective, but they also all emphasized that while a company may hope for a return on its 
giving, a return is not fundamentally expected. Daniel (VP, Business Development) 
explained it this way: 
It’s a grant. It’s not a loan. We give it without expecting a return. So part 
of the definition has to be that while we may have motivations like social 
responsibility or profit motive or whatever, in the end, corporate giving has to 
be an emphasis on no strings attached as opposed to a contract we sign with 
somebody… We may hope certain things happen but we certainly send it out 
with the expectation that it’s not coming back.  
 
All participants communicated a feeling that companies should be honest about their 
intentions for corporate giving. Doug, SVP, Research and Development, was the most vocal 
about the need to recognize the basic motivation of corporate giving.  
So, if Merck [not a company interviewed for this research] wants to give 
a hundred million dollars to help underprivileged children in Africa, the money 
goes there, that’s wonderful! Are they doing it because they are in trouble now 
and they want to get their name better out there? It’s okay with me as long as 
you recognize that, that they are doing that for that reason, or in part for that 
reason. 
 
Most importantly, all participants communicated that while it is important to be honest about 
intentions, there is nothing wrong with a company expecting its corporate giving initiatives to 
provide some benefit for the company. “Corporate giving and getting? Well, I don’t see 
corporate giving as writing a check and saying goodbye. I mean the truth is, we are in a 
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business. We’re not ashamed of that. We’re proud of that” (Linda, VP of Global Corporate 
Affairs).  
The Cycle of Opportunity 
 A “cycle of opportunity” (John, President), emerged as a key finding that links the 
notion of corporate giving within the healthcare industry to building industry partnerships 
and therefore making more of an impact on the cause a company supports and the benefits 
for the company itself. The cycle of opportunity, discussed at length in the following chapter,  
demonstrates that a strategic approach to corporate giving can bolster the core business of a 
company. 
Stay in the industry.  All participants discussed the strategic benefit of corporate 
giving programs being aligned with the healthcare industry. Staying in the industry provided 
more strategic benefits than giving that was not aligned with the healthcare industry. 
Therefore, all companies interviewed gave the majority of corporate giving funds to 
healthcare-related causes.  
John (President) said healthcare is an easy thing in which to engage and therefore it 
makes sense to stay in the industry with corporate giving: 
Healthcare is an interesting thing, it’s very easy to engage. I do think it’s 
a little harder when you want to support the symphony because somebody says 
well, I’m not into classical music and somebody else says they are. You know, 
let’s list the people who are into helping a child who’s going to die today. So 
we’ve got a little bit of a natural kind of tailwind that goes with healthcare and I 
think facilitates this.  
 
Karl (VP, Planning and Contracting) said it is about staying in the industry and aligning 
giving with the mission.  
Because our business is healthcare and curing people and extending life, 
so I think they try to stick with our mission. You know, if we were a tobacco 
company, charitable giving would be something very different from what the 
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core business was. But with healthcare it’s a little easier to have charitable 
giving that lines right up with what you do for business. 
 
Linda, Vice President of Global Corporate Affairs, agreed with the need to align giving with 
the healthcare mission.  
There’s definitely alignment with our mission. You know, if we had limitless 
money, yes, we’d love to give to every disease. But since we don’t, and since we’re 
not even a profitable company yet, we’re very specific and careful as far as how we 
donate, and that’s been our philosophy thus far. 
 
No corporate giving budget is limitless. Catherine talked about the importance of 
using the money in a focused way. “So, you’ve got so many dollars, where are we going to 
focus them? Well in the disease areas where we’re doing business because our employees are 
interested in that, too. Our shareholders are interested in that.” All participants expressed a 
desire for corporate giving to be connected to the core business of the company.  
 Ben, Senior Director of Media Relations, described that several forms of his 
company’s giving ultimately supported healthcare: 
We are very focused on healthcare kinds of philanthropy, like AIDS 
programs in the U.S. and then in Africa. We’re also focused on programs that 
promote scientific—people going into scientific areas or math areas because 
they are the people who come and develop drugs. So, we, you know, we have a 
scholarship for medical journalism. Again, it’s focused on the medical aspect. 
So, I think…much of its giving is very targeted and very strategic. 
 
Staying the industry also makes sense because “it’s like they have a need; we have an 
expertise” (Danica, Director of Media Relations). All participants cited an expertise in 
healthcare allows them to give a special kind of support to healthcare needs through 
corporate giving programs.  
Where there is strategy, I think that we focus on where our expertise is. 
We are a healthcare company. So in our giving, those are the types of things that 
we support. We support science education and we support programs that 
promote global healthcare, and that’s who we are. (Danica, Director of Media 
Relations) 
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Sam, Senior Director of Government Reimbursement and Policy, concurred. His company 
markets several HIV treatments, and therefore much of their “corporate benevolence” is 
geared toward developing countries where the AIDS epidemic is rampant. “Because we have 
those products in our portfolio…because again it’s very focused on our areas of expertise, 
we’re not trying to be philanthropic in areas that we don’t know.” Product alignment and 
topic expertise provide strategic direction for corporate giving.  
Participants’ corporations do not just give to any healthcare-related cause. They target 
corporate giving to specific healthcare causes as they relate to the products of the company. 
“Why would I give to, I don’t know, the Arthritis Foundation, when all of my shareholder 
money and my research dollars are in cancer? You know, it makes sense” (Linda, VP of 
Global Corporate Affairs). Garrett (SVP of Sales and Marketing) talked about a 
pharmaceutical company he worked for in the past. While he wanted the company to support 
an epilepsy foundation, the company agreed with the good healthcare cause, but ultimately 
the company did not have an interest in that area because it was not developing treatments for 
epilepsy. Garrett said the company wanted to use corporate giving funds for diseases that 
were more aligned with its business. “That’s a hard thing to argue with because there are a lot 
of worthy things, you’ve got to pick.”  
 Partnerships—a goal of corporate giving. All participants agreed that companies 
derive a strategic benefit from corporate giving when they focus their giving on the 
healthcare industry—staying in the industry creates a cycle of opportunity. Seven participants 
took the notion of staying within the industry to the next step specifying that establishing 
partnerships in healthcare is a strategic business objective of corporate giving. Partnerships 
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create long-term opportunities to provide resources to a trusted group and build relationships 
that are more valuable than a simple one-time cash donation to a cause.   
 John’s company even uses the term “partners” to refer to the group of nonprofit 
organizations to which it lends supports through corporate giving. “I think it’s a pretty 
interesting approach again we’ve taken where we look at large public organizations focused 
on healthcare and we determine if there is a mutually beneficial way for us to partner with 
them and pursue any specific topic.” He explains that through partnerships, more can be done 
than simply donating money.  
We have a good understanding of the issue. So rather than just being 
able to send money or ideas or people, we can also engage with people on what 
else could be done…the trading of insights and ideas and opportunities to really 
make a difference is accelerated. 
 
Karl supports partnerships as long-term giving commitments. “The long term is the 
stuff that matters. You can’t really plan around short term contributing. So what matters is 
that you keep doing the same thing over and over and over again so the same people can rely 
on your money.”  
 Partnerships bring strategy and therefore benefits to otherwise untargeted giving. For 
example, Ben talked about his company’s Hurricane Katrina relief efforts. Instead of just 
writing a check, his company identified areas where they felt their expertise could help build 
a long-term partnership in the area. They donated money to rebuild hospitals. “We identified 
some areas that we felt we wanted to contribute to that would have long term benefits, long 
after just feeding and clothing people next month. They’d have a hospital for years from now 
to train medical professionals to be able to serve in the long term.” 
 Danica said “partnership is key theme for us.” Going back to Hurricane Katrina relief 
efforts, her company set up partnerships with pharmacies in the Gulf state region to 
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reimburse them for drugs they provided to evacuees who had prescriptions for the company’s 
medicines. “We focused on partnerships; so with everything that we’ve done in this relief 
effort, again, it was partnerships, partnerships, partnerships.” 
 Linda described her company’s support of third-party patient advocacy groups, 
emphasizing the partnership her company had with those organizations rather than solely 
focusing on a marketing-based interaction with them. “They depend on us not only for funds 
but also for information, for access to other types of resources. And so it’s more a 
partnership.” She also talked about how her company positions itself as a partner: 
We’re not just throwing around money. And I’ve seen other companies 
do that. They’ll, like, write a million dollar check and think, “okay, well, now I 
own that organization.” Maybe it does work like that in some places. It doesn’t 
here, at least not with the oncology group who I’ve been working with. And we 
don’t have a million dollars to write a check! So, we like to position ourselves 
more as partners and colleagues as opposed to, you know, “here’s your money.” 
 
Sam also talked about the importance of partnerships as doing something more than just 
handing over a check. His company set up a hospital in Africa. 
If we helped build the infrastructure, you’ve heard the saying, “Give a 
man a fish and he’ll eat for a day; teach him how to fish and they’ll eat for a 
lifetime,” and I think that’s really what we tried to do. You know, you could 
give them something, but that would only meet their immediate [need]; if you 
helped them develop the infrastructure for healthcare, then you were going to 
help them to be self-sustaining.  
 
Impact—the result of industry partnerships. Strong partnerships make an impact. 
Four participants communicated the ability of healthcare industry partnerships to make a 
large and important impact that would otherwise not be realized. John described the link 
between partnerships and impact: “The partnering piece is probably the piece that’s been the 
most critical because it really allowed us to, again, have the surprisingly larger impact that 
we thought we might be able to have.” He also described his company’s focus on healthcare 
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causes in developing countries, because helping kids in Africa with neonatal tetanus (a 
disease for which his company has a treatment) is more impactful than giving money to well-
funded cancer initiatives in the developed world. “The ones we decided to do tend to be 
pretty impactful to people in healthcare.” 
 Ben agrees. “If you don’t target it you don’t necessarily have a real big effect on 
anything… It’s [corporate giving] very selective and we’re giving to programs we think can 
make the most difference.” He likened it to the giving strategy of the Bill and Melinda Gates 
Foundation. “They are picking areas of interest where they think they can—that giving 
twenty million dollars will have a dramatic effect. There’s so much money that could be 
thrown at so many—I mean, AIDS, you could throw hundreds of billions of dollars at that 
problem and not solve it.”  
 Garrett said his company prefers to make a long-term commitment to healthcare 
nonprofits. “I think that those types of programs probably have a longer impact than just the 
one-time donation for hurricane relief.” Danica said her company wants to end trachoma, and 
the company provides the medicine to do so throughout Africa and Asia. The company looks 
at “reach” to determine the number people impacted by a corporate giving program, and 
bases its decision to provide funding on that measurable impact.  
Benefits of Core Business Corporate Giving 
 Participants discussed the benefits of a strategic approach to corporate giving to 
bolster the core business of a company. Competitive advantage, the indirect influence of key 
stakeholders, relationship building, effect on sales, and corporate image are important 
considerations when determining strategy in corporate giving.  
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Competitive advantage. None of the participants perceived corporate giving as a 
concrete way to absolutely secure competitive advantage. Five participants, however, said 
that corporate giving does help gain access to certain groups, establish relationships, and can 
help with public opinion. Whether these benefits translate into direct competitive advantage: 
“that’s a hundred million dollar question” (Ben). Linda answered this question by saying, 
“Well, if you look at relationship building as competitive advantage, and I do, then 
absolutely, yes [corporate giving creates competitive advantage]. Absolutely, and anyone 
who tells you ‘no’ is not telling you the truth.”  
 Ben explained corporate giving’s ability to help capture the attention of an audience.   
 
Certainly if you go into a meeting with the FDA and they have a 
favorable view of you based on some of the things you’re doing that they 
believe in and in addressing healthcare issues, they are going to look more 
favorably on you than they would otherwise. Does that mean they’re going to 
approve a drug that shouldn’t be approved? No. But, it may mean that you get 
an audience to talk about the drug when you might not otherwise… There are 
benefits, I think, but I don’t know if that ever gives you a direct competitive 
advantage. 
 
John also talked about access. “These things don’t win you business. But I do think they win 
you, a lot of times, access and maybe the chance to speak—to talk—to really senior 
healthcare decision makers around the world who are aware of the work that you’ve done.” 
Sally discussed competitive advantage resulting from corporate giving improving the 
reputation of a company. “I think in instances, for example, like J&J and Merck, it probably 
at least creates a view of people of the company and what they stand for, so I think it could. I 
think it could help.” 
 Indirect influence. While participants did not see corporate giving as creating direct 
competitive advantage, five did talk about more indirect ways of creating advantage through 
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corporate giving. Five participants also talked specifically about the importance of corporate 
giving in a business that relies on indirect influence to market products.  
You know, it’s [corporate giving] one of those tawdry things that you 
never hear people talk about it directly affecting the bottom line; but we’re in a 
business-influenced management…. Here, we’re in the business of 
intermediaries where it’s a doctor that decides what drug you get prescribed… 
There is actually a legal barrier there that we can’t influence directly the patient 
or only under very limited circumstances. So anyway, it’s a different kind of 
business in that we’re used to indirect influence…Do we think about who we 
spend our money and corporate giving and social responsibility in terms of how 
it may influence something in the future that could benefit us, the answer is yes. 
(Daniel) 
 
Catherine discussed corporate giving as a way to garner indirect influence, but concentrated 
on not crossing a line that interferes with making the right decision for an individual patient. 
“If you give money to the patient advocacy group, is that bad? And my point is, only if it’s 
going to start to interfere with the independent decision making of a physician with respect to 
that patient.”  
 Sam said his company is aware of the strategic importance of corporate giving’s 
ability to indirectly influence important constituencies. “We probably gave away close to 
fifty million dollars worth of product last year, and by doing that we know strategically that 
sits well with legislators, that sits well with policymakers.” 
 Relationship building. Relationship building stands out as one of the principal 
strategic benefits of corporate giving. Ten of the participants cited relationship building as 
the most important benefit of corporate giving as it is related to bolstering the core business 
of a company. While no one said corporate giving directly contributes to the bottom line, ten 
said relationship building is a strategic business goal of corporate giving. Participants talked 
about the benefit of contributing to the “top line” (John), building trust with partners, and 
coming closer to patient, physician, and government stakeholders.  
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John explained his perception that corporate giving contributes to the top line of a 
company by building relationships that pay off in the long term. He refers to contributions to 
the “top line” as strategic initiatives that will, in time, contribute to the bottom line because 
they improve the performance of the company in some way.  
I think they contribute to the top line. And the point is with the kind of 
programs that we are talking about here and the way that we manage this, we 
are trying to work with people on new products, new ideas, major healthcare 
problems, these programs obviously are not profitable but they do tend, over 
time, to generate some additional sales around the world that you may or may 
not have gotten… Just continuing to think about the rest of the world as a key to 
your long term growth performance and the products you bring to the market, 
that’s a plus. 
 
John’s company engages in corporate giving in much of the developing world as part of its 
global growth strategy. “Most of the strategy is based around relationships and the ability to 
make important, if you would, connections around the world… those are just good business 
relationships to have.”  
 Danica said her company uses corporate giving to build relationships that create trust 
between her company and its partners. In finding partners to give out free drugs, “these were 
organizations that we’ve worked with, we have relationships with, so we know how they 
work. We know that they have resources on the ground. We know that they are plugged into 
distribution channels on the ground and know how to receive medicines and get them out.”  
 Linda thinks corporate giving to patient advocacy groups brings the company much 
closer to the patient and allows the company to then better serve the patient. “We’re really 
able to get better understanding of what issues they’re facing.” She also said the company is 
not looking at how much money they are giving to these groups, but what kinds of 
relationships they are building.  
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It’s not per dollars spent, by the way. It’s per relationship…I mean, like 
in anything in life, it’s no different in business. It’s the same thing all around. 
It’s all about, it’s who you know, what you know, it’s being able to bounce an 
idea and call you up and say, ‘hey, do you think patients would go for this? Is 
this something where there’s a need for this?” versus me doing a thousand focus 
groups and they trying to sell it in. 
 
Garrett also sees corporate giving as building relationships that bring a company closer to its 
stakeholders. “There’s a benefit to giving away drugs because again, we are interacting with 
physicians…it’s not a huge cost and it’s kind of the cost of doing business.” He said many 
companies will sponsor charitable golf outings because “the company gets put in a positive 
light and perhaps some of your executives get to play golf with these people, so there’s a 
relationship established.”  
 Direct commercial interest. Ten participants discussed in some form the connection 
between corporate giving and direct sales. John said that generating products sales as a 
benefit of corporate giving initiatives is good, but sales generation as a purpose of corporate 
giving initiatives is disingenuous.  
If the expectation is that the proper selection of a problem, the allocation 
of resources to solve that problem ends up being a positive impact on the 
problem in terms of outcome and then as a secondary outcome, generates 
additional sales, that’s fantastic. That’s good…we are not naïve here; if we get 
some more sales from UNICEF or somebody, great. But it’s not the reason to do 
it. But if the reason to do it is to primarily generate sales and maybe along the 
way we’ll have a positive impact, these are very different strategies. (John) 
 
Catherine talked about the need to at least perceive corporate giving as being separate from 
commercial interests, and agreed with John’s view that sales should not be the primary 
reason for giving. “To say that there can be absolutely no commercial interest at all is so 
naïve… [corporate giving and commercial interests] are perceived as being somewhat 
separate… you’re doing this because it’s the right thing to do, not because you think you’re 
going to get more scripts [prescriptions] at the end of it.” 
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Karl said that corporate giving can cause lost sales. “I mean it’s viewed two ways. 
One is ‘we’re giving away free drug,’ and the other way is, ‘we’re giving away free drug,’ so 
you have the feel good side of it and the other side is hmm, were those lost sales?” Ben 
thinks sales can be affected by corporate giving, but not by much because “philanthropy is 
not going to be as targeted as marketing is.” Linda agrees, “If you do it [corporate giving] as 
a sales technique, I don’t think that’s really corporate philanthropy or giving. I think that’s a 
fancy way of saying, ‘marketing dollar.’” Garrett does believe corporate giving is used in 
place of traditional marketing and advertising techniques at times, but mainly from the 
standpoint that drives “access or awareness or recognition without a direct financial benefit 
to the company that you can measure.”  
Corporate image. In addition to relationship building and commercial benefits, nine 
participants cited corporate image as a strategic benefit of corporate giving. Image is 
especially important in the pharmaceutical industry because of the negative publicity 
companies often receive.  
One of the selfish motivations is anything we can do to enhance the 
image of the industry; and the company, being part of that industry, is just a 
natural because we’re always subject to the next 60 Minutes episode on why 
drugs cost three cents a pill and they charge $50. So the industry, just in general, 
has an image perception challenge… any things we can do from a responsibility 
standpoint offset that—or help buffer that a bit. (Daniel) 
 
Doug said no matter what philanthropic causes a company might be involved in, “You can 
make an argument that even at that level you’re doing it because it has a positive spin back 
on your company.” He believes that all corporate giving has a selfish motive, even if it is for 
an incremental boost to the corporate image.  
 Sam’s company was one of the first to donate a large amount of money to the 
Hurricane Katrina relief efforts.  
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It was more of a corporate front, meaning to show we need to set the 
example… You lead by example and I think that [our company] was looking to 
be a leader in trying to meet the needs… So if you have a good public position, 
or you’re seen as a good figure in corporate media, then you absolutely get the 
benefit of that, I mean that helps you. 
 
He explained that it was not just about helping an area in need, but in positioning itself as a 
corporate leader for the benefits that would lend to its corporate image.  
So, Is There Strategy or Not?  
The previous section discussed the benefits of strategic corporate giving, and 
participants all agree that to a certain extent their companies are strategic about corporate 
giving. Their perceptions of the level of strategy behind their companies’ CSR and corporate 
giving initiatives varies. Daniel said, “there’s very little.” Ben said his company’s corporate 
giving is “very targeted and very strategic.” Linda said, “sometimes, yes. And there has to 
be.” For Garrett, it depends, “Depending upon the type of initiative, there might be more 
strategy behind it than another initiative.” Sam said, “I think there is a good deal of strategy 
behind any of our benevolence programs… There’s absolutely a strategic business goal.” The 
bottom line is that corporations are giving resources to society, and as Karl said, “I don’t care 
what motivates people. All I care about is what they do.”  
Negative attention 
 If there is strategy behind corporate giving, then corporations must face the music 
when their efforts are perceived as less-than-honest.  
The only harm is that any benevolence is taken out of context, and so if 
it is taken out of context, it is seen as being too strategic, then it could be 
harmful for manufacturers. But then again as a manufacturer, we’re here for the 
long run… they’re not going to stop giving, I mean, because of bad press 
associated with perception, or you know, people taking it out of context…. We 
can always be seen as too strategic in our giving, and it not being looked at in 
sincerity, you know. (Sam) 
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Daniel agrees that questions of insincerity should not hinder giving. “So there is always 
going to be skepticism about corporate giving that I just think comes with the territory, and 
we should neither let that scare us away or deter us… I don’t see it deterring us or really 
changing our strategy simply because people may question whether we have other 
motivations.” 
 Having presented the findings related to using CSR and corporate giving to enhance 
the core business of the company, I will now present the findings describing CSR philosophy 
of the organizations as perceived by the participants.  
CSR Philosophy 
Previous sections discussed how the foundation of a company’s mission and culture 
feed into two approaches of thinking about corporate giving: an employee-community 
relations approach, and a core business approach. These approaches meet when executives 
discuss the basic CSR philosophy of their companies—including how they personally define 
CSR and corporate giving, and how they see it as similar to personal giving.  
Corporations give like people give. Four participants discussed that corporations are 
not much different from people when it comes to decisions about giving. Catherine said, “I 
think it’s really not all that different than the decisions that you go through personally about 
where you’re going to give. And you end up giving to things that you’re somehow connected 
to…things where I feel like it’s going to make a difference in something that I care about.”  
Doug explained that personal motivations for giving are similar to corporate 
motivations— that there is an image or recognition component that sometimes drives giving. 
“When someone donates $10 million to put—start a new building, they are doing it because 
they think it is a great cause but their name is also on the building and that gives them some 
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benefit there as well.” Daniel expressed a similarity in a person and a corporation having a 
conscience. “It’s an interesting thing to see an entity like a corporation almost have a 
consciousness…and are we a collection of souls here or just an entity that’s there to drive 
profit and bottom line?” 
Definitions of CSR. Ten participants defined CSR as doing something to enhance the 
environment in which their company exists. John defined that environment as healthcare. 
“We are a healthcare company so we look at major healthcare issues and the question 
becomes what responsibility do we have to take visible and impactful actions to offer 
improvement or ideas to make something better?” Six participants defined the environment 
as the community. “A corporation derives its living out of the community so it has some 
responsibility to provide for the welfare of the community as well” (Karl). Doug described 
the environment as a company’s constituents. “So I would define it [CSR] as the 
responsibility of any organization to be giving back to, I would say primarily the constituent 
groups that it serves.” Sally said the environment is the objectives of a company. “I believe 
companies, no matter what industry, have social responsibility and I think it has to be 
consistent with the objectives of the company.”  
Sam was the only one not to refer to CSR as a responsibility to an environment—
healthcare, community, constituents, or corporate objectives. Sam defined CSR as a tool of 
proactive public relations. “I think it’s [CSR] a proactive public relations approach versus 
reactive. Whenever there seems to be reactive public relations, they seem to be firestorms, 
and when you’re proactive with your corporate benevolence…it doesn’t seem like we’re 
trying to fix a problem… Everything under benevolence gets plowed back into the public 
relations.” 
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Seven participants also said CSR is being a good corporate citizen. Daniel’s company 
engages in CSR because they want to be “a good corporate citizen.” Ben and Danica’s 
company reports on CSR initiatives through a corporate citizenship report posted on its 
website. Linda said being a good corporate citizen is the broad definition of CSR for her: 
“not polluting and adhering to all the rules and regulations of that state and city and federal 
government, you know, Fair Trade Act, and all that kind of good corporate behavior.” Sam 
sees his company as embracing corporate citizenship as an overall CSR philosophy—and it is 
a part of the company’s overall growth. “We’re trying to not only continue to expand out 
product line, continue to expand our presence, but we are trying to represent that we are good 
corporate citizens.” 
An ethical business commitment. All participants discussed a general commitment to 
ethical business. John talked about how in tackling a healthcare issue, his company looks at 
the issue from a commercial and philanthropic standpoint. “What is it we can do, 
commercially? What can we do charitably? How can we figure all this out?  Don’t think that 
this is some charitable organization, it’s not that. I think what we are trying to create here is 
this almost natural and comfortable blend of doing both.”  
 Four participants talked about the ethical commitment to prescription drug pricing. 
Garrett said his company thinks about the price in the context of its implications for all of the 
company’s constituencies. “I think that’s a very socially responsible way to evaluate price 
increases, and so I think that that extends to the definition of social responsibility to, not just 
the product you make, but are you pricing it fairly.”  
 Doug discussed the ethical commitment to families involved in drug trials. “I think 
we have a responsibility, we could not develop a drug without patients and their families 
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being willing to try an experimental drug. By itself that says that we have a social 
responsibility to give back to that community. If we don’t, I think we fail in our true mission 
of helping patients.”  
 This section included the findings of how participants perceive the overall CSR 
philosophy of their companies. Next, I will present the findings of how participants perceive 
market pressures to affect the CSR philosophy—and particularly the corporate giving 
initiatives—of their organizations.  
Market Pressures 
 Market pressures inevitably affect a corporation’s ability to do business, and therefore 
market pressures also affect a company’s ability to engage in corporate giving. Karl 
discussed the market pressures on the pharmaceutical industry as a whole.  
Margins are shrinking. It’s easy to give money away when you have fat 
margins. The test is what do you really believe in when things start to get 
tighter? So, I would say the whole industry is facing tighter margins and now 
saying, oh, wait a second, we need this money to be able to meet our results for 
the quarter. So can we really afford to give something away that we can’t tie 
back to business? 
 
There is also the inevitable pressure of Wall Street and shareholders for companies to act in 
ways that improve their position in the market.  
Our shareholders would expect us to be thinking broadly about how we 
spend every dollar here. And I think they do expect us to fulfill a corporate 
obligation, corporate giving, social responsibility. I think they accept that’s a 
part of our mission. But I also think that they would expect, like any other dollar 
we spend here, that thought goes into it and that it has a strategic component. 
(Daniel) 
 
The smallest company included in this research faces extreme market pressures 
because the company is not yet profitable. “Corporate giving—I would not put that as a high 
priority in this company anymore. That’s my sense because there are very few dollars to 
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allocate there. Corporate giving without the giving is hard” (Doug). Sally put it best. “If you 
don’t have results, the company’s not here and therefore, the company can’t produce or 
contribute going forward, but it’s sort of balancing those, making it an equal priority.”  
 Market pressures are a fact of the business world, and they force companies to 
thoughtfully consider all business decisions, including those regarding corporate giving. In 
the next section, I will present the findings of how companies are becoming more strategic 
when it comes to corporate giving. 
Becoming More Strategic 
 The previous section discussed the market pressures facing corporations and how 
those affect corporate giving. Due to the intense focus on how companies spend their money, 
it makes sense that there is an overwhelming sentiment that corporate giving is becoming 
more strategic.  
I’m not sure what we would have talked about five years ago in this 
interview. I would have told you about oh yeah, we give to the symphony and 
oh yeah, we bought stuff for the school in Sumter. And it would have been 
interesting but I don’t think it’s as interesting as where we are at right now. 
(John) 
 
Daniel, from one of the smaller companies included in the research, explained that a 
more mature organization has more time to think about corporate giving, and therefore more 
time to be strategic. “We’re not in survival mode, so it’s the beauty of maturing as an 
organization…that we can actually take time to think thoughtfully about those kinds of things 
like corporate giving.” Catherine agrees. Her company has become more mature in the past 
three years. “My bet is that what you had was lots of planting trees by local soccer fields and 
not sort of a thought about ‘how are we going to do this.’” She thinks there is more thought 
and strategy put into corporate giving than in past years. Ben works at one of the largest 
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companies involved in this research, yet he feels like his company becomes more strategic 
over time, too. 
I think a lot of companies, including our’s, have gotten more strategic 
with their giving over the past several years anyway. It used to be that 
companies would tend to give to programs if they were asked or if they saw a 
need and there was no—it wasn’t giving that was tied to the business; it was just 
kind of scatter shot. And, for a variety of reasons, I think, many companies have 
gotten more strategic, and our’s certainly has. 
 
Summary 
Research interviews with eleven participants revealed common themes in the 
perceptions of healthcare executives in regards to CSR and corporate giving. Participants 
discussed the culture and mission of their organizations, how that foundation is supported by 
leadership, and how it affects two approaches to corporate giving: employee and community 
relations, and core business corporate giving. Participants described a cycle of opportunity 
when corporate giving is based within the healthcare industry, and they outlined the benefits 
of such a strategy. Executives also discussed their companies’ general philosophy of CSR, 
how market pressures affect their actions, and finally, the strategic direction corporate giving 
is taking. In this chapter, I presented the full findings of the research. In the following 
chapter, I discuss the implications of these findings and specifically answer the research 
questions posed in this thesis.  
CHAPTER V 
DISCUSSION 
 
Corporate giving and getting—the title of this work—explains it all. Corporations are 
often out there to get something for their good deeds, and that can be a good thing both for 
the beneficiaries and the company itself. The executives I interviewed were forthcoming with 
their opinions about CSR and corporate giving, and none were ashamed to say their 
companies have a desire to benefit from corporate giving. All stakeholders, including 
shareholders, could read through the research and feel good about how executives view 
corporate giving. They strive to run a profitable company, and they also want to contribute to 
society. They are equally sincere in both desires.   
The research yielded many noteworthy findings that are consistent with the literature 
reviewed for the study. Studying the niche of healthcare companies revealed the fascinating  
ability to engage corporate giving within the industry—healthcare provides a universe of 
opportunity to improve society that is often consistent with the products and services offered 
by the companies.  The executives described the myriad initiatives aimed at helping improve 
healthcare worldwide, from their commercial operations to corporate giving. They have the 
ability to engage the industry and bring forth change and progress. In this vein, the most 
interesting findings from the study emerged from the link between the commercial side of the 
healthcare industry and the opportunity it creates for charitable activity. To explain this 
relationship, I will discuss the industry-partner-impact model of corporate giving that came 
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to light during the research. I will also discuss other research findings, the contribution to the 
study of CSR, limitations of the study, and avenues for future research.  
Industry-Partner-Impact Model of Corporate Giving 
The most interesting research finding relates to what one participant labeled the 
“cycle of opportunity” (John). Healthcare companies that are able to focus corporate giving 
within the healthcare industry and use corporate giving to develop relationships and 
partnerships within the industry make the most impact on causes they support and garner the 
most benefits for the company itself. This creates an industry-partner-impact model of 
corporate giving.  
Figure 3. Industry-partner-impact model of corporate giving. 
 
Give within the industry. Focusing corporate giving within the healthcare industry 
also keeps giving aligned with the mission of the company. Many of the companies I 
interviewed include public health as part of their general mission statement. Much of the 
literature supports the view that if a company gives to a cause well-aligned with its mission, 
it will further the business interests of the firm (Burke & Logsdon, 1996). Companies have 
Make an impact
Cycle of 
Opportunity 
Give within the 
industry Establish partnershipsBuild relationships 
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limited funds and they must find a way to focus limited resources, so it only makes sense to 
focus those resources on the healthcare industry and mission of the company.  
Corporate giving focused on the industry and the mission can bring benefits not only 
to the external business interests of the company, but is also helps to keep employees 
engaged with the mission of the company. It makes sense to give within healthcare to keep 
employees engaged, rather than to give to an unrelated cause, such as the symphony, which 
has no connection to the company’s mission or industry.  
Keeping corporate giving within the healthcare industry also allows a company to 
match its expertise to a cause. A company can do more than just give cash—by staying 
within healthcare, they can offer their expertise and knowledge, which are arguably more 
valuable than a simple cash donation.  
Establish partnerships and build relationships. The idea of corporate giving being 
engaged within the healthcare industry lends itself to the development of partnerships within 
the industry. Corporate giving may create partnerships with nonprofit organizations, other 
corporations, domestic and foreign governments, customers, and a range of other 
stakeholders. When a pharmaceutical company allocates funds to the local symphony, it 
creates a relationship with the symphony that is not aligned with the business interests of a 
company. When a pharmaceutical company, for example one who markets an HIV product,  
builds a partnership with the government of an African country to deliver AIDS care to 
people in need, the company establishes a long-term relationship that may mean future sales 
to that country, or simply a closer relationship with the government that will allow the 
company to have a better understanding of developing markets. These benefit the core 
business of the company, allow a partnership to grow, and society to benefit. Corporate 
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giving within the industry builds partnerships and relationships that bring companies closer 
to their stakeholders.  
Make an impact. When a company gives within the industry and builds relationships 
within the industry, it is possible that the impact of corporate giving initiatives will be more 
intense. The company is inherently better prepared to make an impact when corporate giving 
is targeted in ways that match with the company’s industry and mission and is used to 
develop relationships with key stakeholders. In many respects, this industry-partner-impact 
model of corporate giving comes down to engagement. A company that engages its industry 
and stakeholders through corporate giving can make a larger impact on society and engage its 
own business interests at the same time.  
As one participant said outright, relationships do create competitive advantage 
(Linda). The industry-partner-impact model of corporate giving depicts the cycle of 
opportunity created when a company gives within its industry, builds partnerships, and thus 
makes a greater impact. While this may not contribute directly to the bottom line, it does 
show the value in building relationships that benefit the company. These relationships can 
create competitive advantage. Much of the literature argues about whether or not corporate 
giving is tied to the bottom line. Virtually impossible to measure, it is difficult to make the 
argument that corporate giving has a direct connection to the bottom line. It is simple, 
however, to recognize that strategic corporate giving can serve a multitude of business 
interests. Most importantly, it can help to build relationships with key stakeholders.  
As companies begin to realize the potential of corporate giving to fulfill business 
goals—such as relationship building—they seem to be on track for corporate giving to be 
more strategically focused. Of the executives I interviewed, all agreed that their companies’ 
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giving is becoming more strategic over time. This corresponds with the literature from Saiia 
et al. (2003) that companies recognize the strategic value of corporate giving and now expect 
it to continue to provide value.  
 While strategic corporate giving is important as a way to benefit both society and a 
company, there is something to be said for keeping the “flavor” (Ben) of corporate giving. In 
fact, if a company could make an argument that corporate giving is tied directly to the bottom 
line, the company may lose some “brownie points” with employees and other stakeholders. 
Perhaps it is the best of all worlds when corporate giving is indeed giving back to society 
without a blatant tie to company profits. Relationship building, however, is a way a company 
can strategically benefit from corporate giving without losing the “flavor” of corporate 
giving.  
 John talked about the importance of giving in the healthcare industry, establishing 
partnerships, and making an impact in a way that is beneficial for the company but not 
necessarily a direct commercial interest. Consistent with the literature and this industry-
partner-impact model, John describes the concept: 
If you are going to do stuff like this, you’ve got to do it in the sense of a 
broader purpose, just decide how much money you will or will not spend, 
decide how many people you will volunteer or not volunteer…You do it 
because it’s the right thing to do… The question is how much extra money do 
you have, where are you going to spend it…Just make sure you’re not just 
throwing the money and walking away and come back two years later and said 
oh nothing came out of this.   
 
Applications to other industries. This industry-partner-impact model of corporate 
giving emerged from the data I collected from executives at healthcare companies. As 
they discussed, healthcare has a “natural kind of tailwind” (John) that allows these 
companies to easily engage in corporate giving initiatives that match to their mission and 
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core business of healthcare. The literature supports the idea that companies should 
engage in corporate giving that complements their mission, but the literature does not 
take the next step to say that companies should give within their specific industry.   
The healthcare industry is one that is easy to engage, as the participants discussed. 
The automotive industry, for example, is not as natural of an engagement—General 
Motors (GM) is not going to start giving out free cars to people who cannot afford them. 
While perhaps less immediately evident, other industries, including the automotive 
industry, retail, hospitality, and others could potentially apply the industry-partner-impact 
model of corporate giving and derive strategic benefits from doing so. It requires finding 
a way to engage with your industry and build mutually beneficial relationships with 
stakeholders using the tool of corporate giving.  
 Healthcare’s natural level of engagement between core business and corporate 
giving might be the key to this “cycle of opportunity,” but other industries may also be 
able to find ways to derive strategic value from corporate giving within their industries. 
Future research needs to be done to determine how this model might apply in industries 
beyond healthcare; specific ideas for future research will be discussed later in the chapter.  
Corporate Giving Process Model 
 As depicted in Figure 2, the corporate giving process model outlines how 
companies may think through their approaches to corporate giving, based on their 
mission and organizational culture, and resulting in the more strategic management of 
corporate giving. While this process model emerged from the participants I interviewed 
in the healthcare industry, two important considerations should be made in regards to this 
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model: does it apply to other industries, and are there others factors that encourage 
companies to become more strategic?  
 Applications to other industries. As previously discussed, the models emerging 
from this research may be less readily applicable to other industries. Specific to the 
corporate giving process model, other industries may be better able to apply this model 
because it is less industry-specific than the industry-partner-impact model of corporate 
giving. GM, for example, may indeed have a leadership-supported mission and culture 
that breeds two approaches to corporate giving: improving employee and community 
relations, and bolstering the core business. They may bolster the core business through 
corporate giving that is not industry-specific, but still provides strategic benefits to the 
core business of the company. These approaches could define the CSR philosophy, 
influenced by market pressures, and result in becoming more strategic about corporate 
giving. In other words, the process model may describe corporate giving for a wide 
variety of industries.  
Factors encouraging strategic giving. The corporate giving process model is 
undoubtedly a simplified depiction of a complicated reality. The most ambiguous part of 
the model may be the other environmental (non-market) factors that influence companies 
to become more strategic in their approaches to corporate giving and CSR, such as social 
trends, the political atmosphere, or the visibility of the industry. As noted in the literature 
review, scholarship about CSR is moving towards understanding the strategic 
motivations for its practice (McWilliams et al. 2006), so these environmental factors and 
their effect on strategic decisions about CSR would be an excellent inquiry for future 
research.  
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One specific environmental factor—the public visibility of a company—was 
discussed in the literature and is particularly interesting in studying the healthcare 
industry. Healthcare companies are highly visible, and it follows that industries with a 
high degree of public visibility often are more active in corporate giving and often use 
corporate giving to strategically to manage stakeholder relationships (Campbell & Slack, 
2006). The high visibility of healthcare companies could be a vital factor in their quest to 
practice strategic corporate giving. Beyond healthcare, gaining a better understanding of  
environmental factors such as public visibility allows us to make comparisons within an 
industry rather than looking solely at the corporate giving strategy of one company. 
Because all companies in a particular industry would be subject to similar environmental 
factors, research could be done to then compare how companies respond to those 
environmental factors in relation to corporate giving.   
Research Question 1 
 
The first research question asked to what extent do executives at healthcare 
corporations view corporate giving as a means to achieve strategic business objectives? The 
participants I interviewed perceive the majority of their companies’ corporate giving to be 
strategic. They believe that corporate giving is often used to fulfill a strategic business 
objective, and most often that objective is building relationships with key stakeholders such a 
physician groups, patient advocacy groups, government, and employees. Executives do not 
perceive corporate giving as contributing directly to the bottom line, but do realize its ability 
to fulfill business objectives. At the same time, there is a sentiment that corporate giving 
should first benefit stakeholders, and only benefit the company as a secondary purpose. Ben 
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expressed this sentiment well when he said, “There are some business objectives as well as 
just pure philanthropic objectives.  And you use sometimes one to help the other.” 
A Discussion of Other Findings 
 The literature supports corporate giving and CSR activities as improving employee 
morale (Pruzan, 2001). I was surprised, however, by the extent to which participants cited 
employee relations as a major benefit to corporate giving. Employee relations are discussed 
more often in the public relations literature than CSR literature, but its prominence in this 
research shows the overlap between CSR and public relations literature. The conversation 
between the areas of study is not robust, but employee relations is an area where they meet. 
Future research in how employee relations is related to CSR and PR would be an intriguing 
way to further the conversation between the areas.  
 While participants cited relationships as the most important benefit of corporate 
giving, they did not pay much lip service to shareholders. They discussed government, 
customers, employees, patient groups, physician groups, and nonprofits as important 
stakeholders, but rarely did they mention the shareholder. Perhaps this means the shareholder 
is not the most important stakeholder when it comes to corporate giving decisions, which 
would support the idea that corporate giving should first benefit other stakeholders, with only 
a secondary benefit to the company and its owners.  
 Each participant spoke at length about the ethical business commitment of their 
companies. All participants expressed a genuine feeling that their companies wanted to give 
something back to society because it is the right thing to do. Participants communicated a 
feeling that their company should (and does) operate in a way that it ethically and socially 
responsible. They often said they did not apologize for being a business, and that making a 
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profit is obviously the first goal. They were exceptionally sincere, however, in 
communicating a commitment to running an ethical business.  
Research Question 2 
 
The second research question asked to what extent do executives at healthcare 
corporations view corporate giving as a part of their organization’s CSR commitment? All 
participants viewed corporate giving as integral to CSR. The executives did not make a 
distinction between corporate giving and the overall CSR commitment of their organization. 
They each expressed a genuine desire to give back to society through corporate giving, and to 
operate as an ethical business—all of which they perceived as corporate social responsibility. 
As such, this research question yielded less interesting results than the first research question. 
Executives readily assumed corporate giving as part of their organization’s CSR 
commitment. This is consistent with the literature (Brammer & Millington, 2004; Campbell 
& Slack, 2006). 
Research Contributions 
 To the extent that this research has practical value for healthcare companies, I believe 
its value is in the industry-partner-impact model that builds relationships and therefore 
fulfills strategic business objectives. In contributing to scholarly research on CSR, this 
research contributes more specifically to the corporate giving subset of literature on CSR. 
The industry-partner-impact model and the corporate giving process model may make a 
small contribution to the study of corporate giving. As discussed, it would be interesting to 
see if the same patterns occur in other industries. For example, do automotive companies 
concentrate corporate giving on highway safety and other such issues in their industry? This 
corresponds to existing literature arguing that if corporate giving fits with a company’s 
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mission, goals, and values, and takes stakeholders in account, then it can enhance the core 
business of the company (Bruch & Walter, 2005). Perhaps fit with industry is less important 
than fit with mission.  
 Also, as discussed in the review of the literature, much of the study of CSR is moving 
towards understanding the motivations for it rather than its definitions (McWilliams, Siegel, 
& Wright, 2006). This study does make a contribution in helping to understand the 
perceptions of executives when it comes to the strategic value of corporate giving for 
healthcare corporations. 
Limitations 
 The study has several limitations that affect its ability to make an impact on the study 
of CSR and corporate giving. I only interviewed eleven executives, and as discussed Chapter 
III (Method), one cannot generalize the findings from in-depth qualitative interviews. The 
patterns and themes that emerged from my interview represent the individual opinions of 
only eleven executives in the healthcare industry.  
 The participants themselves are not a diverse group. The participants are 
predominantly white males, as you may expect in higher level positions in corporate 
America. A more diverse group of participants may have garnered different perspectives on 
corporate giving.  
 The second research question is also a limitation—it does not dig deep enough into 
the study of corporate giving. Executives readily perceived corporate giving as a part of CSR, 
and there are not any interesting dimensions of meaning to the question. Another study could 
address other facets of corporate giving that would lend more value to the field.  
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My own experience level as a researcher is a further limitation. With more 
experience, I may have been able to push participants to further explain strategy that 
motivates corporate giving at their companies. There is also the issue of researcher bias. I 
previously worked in the healthcare industry, and I believe pharmaceutical companies are 
more socially responsible than they are given credit for by the media. This bias certainly 
affected my questions and conversations with participants.  
 Participants spent from 45 to 80 minutes with me. During that short period of time, 
they only glossed over their perceptions of CSR and corporate giving. It is possible that they 
idealized their companies’ corporate giving initiatives, and only presented a rosy picture of 
the companies’ CSR commitment. Also, my interview questions inevitably were different for 
each participant. I followed the interview guide, but often issues came up in conversation in a 
different order from other interviews, or participants went more in-depth on some questions 
while barely answering others. Every interview was different, and therefore it is difficult to 
fully compare the interviews— the analysis is not an apples-to-apples comparison. 
 Finally, the research only studies the perceptions of the executives—I did not study 
actual corporate giving initiatives within the companies nor did I speak with the decision 
makers who make the final call on corporate giving. I only look at executive perception, not 
actual reality of corporate giving.  
Future research 
 While this study illuminates perceptions of corporate executives, it would be highly 
valuable to conduct a quantitative study of healthcare corporations to determine the 
percentage of corporate giving resources spent within the healthcare industry in contrast to 
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other areas. Executive perceptions can only go so far to help us understand corporate 
giving—at some point this must be studied quantitatively. 
It would also be interesting to discover how these companies go about managing 
partnerships they forge with individuals and organizations in the healthcare industry through 
corporate giving. Do they have dedicated employees to manage those partnerships? How do 
they build those relationships other than through corporate giving resources? A qualitative 
study of how these partnerships and relationships are managed may prove valuable as related 
to stakeholder theory and CSR.  
 I believe there should be more of a conversation between the study of CSR and the 
study of public relations. Huge areas of overlap exist, including stakeholder management.  
There is continuity between CSR and public relations, and the research here shows another 
important theme that relates to both CSR and public relations: employee relations. Future 
research could address employee relations and how it is affected by CSR initiatives and 
managed through public relations activities. This research would hold value in that employee 
relations best practices could emerge from the combined study of CSR and public relations 
theory in approaching employee relations. It would also be valuable in sparking the 
conversation between scholars in CSR and public relations—the two have much to offer each 
other in terms of stakeholder management, employee relations, and other areas of business 
practice.  
As discussed earlier in the chapter, it is unclear whether the industry-partner-impact 
model of corporate giving applies to industries other than healthcare. Healthcare’s natural 
level of engagement between core business and corporate giving might be the key to this 
“cycle of opportunity,” and the same strategic opportunity may simply not exist so 
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transparently in other industries. A study of the automotive industry, retail industry, or other 
vital industries would be intriguing. For example, do Wal-Mart and Target benefit 
strategically from giving within the retail industry? Does relationship building with 
stakeholders result from corporate giving within retail? Also, a study about the professional 
services industry could be interesting. Exactly how would an accounting firm use corporate 
giving within the accounting industry to build stakeholder relationships and make more of an 
impact on social causes while bolstering its core business? Future research in this vein would 
be beneficial to the continuing scholarship regarding motivations behind CSR and corporate 
giving specifically.  
 Finally, a qualitative study of key stakeholder groups and their perceptions of the 
strategic benefit of corporate giving for a company would be an interesting way to see how 
much giving is perceived as goodwill versus selfishly motivated.   
Conclusion 
 Corporations will not simply throw money out the window—they will more often 
choose to give money and other resources to causes that matter to their industry and their 
company. In doing this, they are being responsible to their shareholders and their other 
stakeholders. They are doing something good for society. Could they do more? Absolutely. 
Our government could do more, we as individuals could do more to improve society—and 
we all have a responsibility to do so. The interesting question is how and why we go about 
making contributions to society. As individuals, do we want a building named after us for a 
donation to our alma mater? Do we give to a local community organization because our 
children will benefit from a new program they offer? As individuals, we have our own 
motivations for sharing our time and money. Corporations also have their own motivations 
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for giving resources. While healthcare companies may share some motivations because they 
are a part of the same industry, it is impossible to say that all corporations think of CSR and 
corporate giving in the same way. Through the research, I gained a feeling that because a 
corporation is made up of individuals, the individual desire to contribute back to humanity 
can influence the collective corporation’s desire to be a profit machine. It is a matter of 
finding a way to balance the benefits of corporate giving—for the company and its 
beneficiaries—and the cost of doing so.  
 I attempted to study one small area of corporate giving in the healthcare industry. I 
was pleasantly surprised by the level of giving of the companies I interviewed, and even 
more pleased by the executives’ genuine sentiment that their companies are trying to do good 
things for society. CSR and especially corporate giving are fascinating areas of study, and 
deserve both corporate and academic attention.  
Corporate giving and getting: “I think it all fits together” (Danica).  
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Appendix I: 
 
Interview Guide 
 
Interviewer: Use this guide as a menu of topics to discuss during the interview. The 
session should last approximately one hour. Probes for each question are italicized below the 
question; use these to garner more information from the participant if necessary.  
 
Introduction Script 
 
Thank you for participating in this interview. 
 
Through a series of interviews like this one, I am conducting research about the 
corporate social responsibility in healthcare corporations. I ask that you offer your thoughts 
and share your experiences during this one-hour interview. You do not have to answer or 
respond to any question; your participation is at will. You have signed a consent form prior 
to this interview and you are aware that you are being audio taped. If any of this is not true, 
we will stop the interview now to attend to those matters.   
 
Thank you again for participating. 
 
(Note: the first question will determine the specific terms that the participant uses to describe 
CSR and giving, and every effort will be made to use his or her terminology throughout the 
interview. For example, if the participant uses the term philanthropy to mean corporate 
giving, then philanthropy will replace the term giving in the following interview questions.) 
 
Please begin by explaining your role at the company, how long you have worked here, and 
where else you have worked.  
 
1. How would you define corporate social responsibility? 
 a. Do you define CSR the same way as your firm? 
b. In your company, do you see a delineation between economic, legal, ethical, and 
philanthropic corporate social responsibilities? How? 
c. Do you label those activities differently, for example, is “philanthropy” a term that 
is used often, or are there other “buzz” words? 
 
2. Can you describe the corporate social responsibility philosophy of your company and your 
involvement with it? 
 a. Do you participate in decision-making processes related to CSR  initiatives? 
b. What are some recent giving initiatives your company engaged in? 
 
3. What drives the corporate social responsibility initiatives of your company? 
a. Are there specific departments, committees, or individuals who make decisions 
about CSR activities?  
 b. What are the company’s motivations to engage in CSR activities? 
 c. How are stakeholders discussed as they are related to the social responsibility of  
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your company?  
 
4. How do you define corporate giving? 
a. Can you share examples of what corporate giving means to you? 
b. Do you view corporate giving as part of corporate social responsibility? 
 
5. How much importance is placed on the concept of corporate giving at your firm?  
a. Are senior executives supportive of its practice?  
b. Is CSR a prominent theme discussed among executives?  
c. Are executives encouraged by the C-suite to participate in giving initiatives? How? 
 
6. How does your company view its corporate giving initiatives?  
a. How much “strategy” is there to the corporate giving? How is that strategy 
determined? 
 b. Are there business goals plainly stated in relation to corporate giving? 
 c. Is giving ever a “business in itself” for your company? 
 
7. How are stakeholders considered when giving decisions are made?  
 a. To what extent are stakeholders interests evaluated during a giving decision? 
 b. Are there particular stakeholders that giving is meant to benefit most? 
 
8. What are the main benefits of corporate giving for your firm?   
 a. Is it solely meant to benefit particular stakeholders?  
b. Does it benefit marketing and sales for your company? 
 c. Does giving create competitive advantage?  
 d. Is it ever used in place of traditional marketing or advertising techniques? 
 
9. When you think about corporate giving, what are examples of the most important 
initiatives of your company? 
 a. Did you expect those initiatives to have the impact (or lack thereof) that they did? 
b. Do you perceive long-term giving programs as better than short-term ones?  
 
10. How does your company measure the effectiveness of corporate giving? 
 a. Are there measures about how much it benefits who actually receives it? 
 b. Are there measures about how it benefits your company? 
 c. How would you change (or implement) these measures? 
 
11. How is corporate giving at your company unique in the industry?  
 a. Does being a healthcare corporation make your giving unique? 
b. Are there particular challenges your company faces in its corporate giving? What 
are they? 
 
12. In your company, is being “too strategic” about corporate giving ever harmful to the 
company?  
a. Does the level of strategy involved affect how the business goal of giving is 
fulfilled? 
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b. Can you give me any examples of how corporate giving could be used in a better 
way at your company? 
 
13. How would you change your company’s philosophy on corporate giving if you were the 
CEO? 
a. Do you, personally, believe that corporate giving has the ability to fulfill business 
goals? 
b. Do you, personally, believe corporate giving is more beneficial than altruistic 
giving? 
c. Does the “strategy” of strategic giving make it less meaningful? 
 
14. How has the view of corporate social responsibility and strategic giving changed over 
time for you? Say, in the past 2 years? The past 5 years? 
a. What experiences have you had that have changed your thinking about these 
topics? 
 b. How has your company’s view changed over time?  
c. Throughout the healthcare industry, are companies doing enough? How would you 
change the industry-wide strategy of corporate giving?  
 
15. We have talked a lot about corporate giving.  Are there other thoughts going through your 
head about this topic that we have not talked about?  
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Appendix II: 
 
Consent Form 
 
University of North Carolina-Chapel Hill 
Consent to Participate in a Research Study  
Adult Participants  
Social Behavioral Form 
________________________________________________________________________ 
 
IRB Study # JOMC 05-052 
Consent Form Version Date: 1/4/2006 
 
Title of Study: Corporate Giving: Executive Perceptions at Healthcare Corporations 
Principal Investigator: Courtney Kuhl 
UNC-Chapel Hill Department: School of Journalism and Mass Communication 
UNC-Chapel Hill Phone number: 703-855-0357 
Email Address: ckuhl@email.unc.edu 
Faculty Advisor:  Elizabeth Dougall 
Funding Source: n/a 
 
Study Contact telephone number:  703-855-0357 
Study Contact email:  ckuhl@email.unc.edu 
_________________________________________________________________ 
 
What are some general things you should know about research studies?
You are being asked to take part in a research study. To join the study is voluntary.  
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, 
without penalty.  
 
Research studies are designed to obtain new knowledge. This new information may help 
people in the future.   You may not receive any direct benefit from being in the research 
study. There also may be risks to being in research studies. 
 
Details about this study are discussed below.  It is important that you understand this 
information so that you can make an informed choice about being in this research study.   
 
You will be given a copy of this consent form.  You should ask the researchers named above, 
or staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study?
The purpose of this study is to understand how executives at healthcare corporations view 
corporate giving at their institutions, how strategic they consider the giving to be, and how 
giving relates to the CSR commitment of the organization. We hope to use what we learn 
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from the study to add to the body of scholarly knowledge on corporate social responsibility 
and strategic giving.  
 
How many people will take part in this study?
If you decide to be in this study, you will be one of approximately 10-15 people in this 
research study.  
How long will your part in this study last?
Each interview will last approximately one hour. You may be contacted following the 
interview to verify information or provide additional information, but follow-up commitment 
is expected to be at a minimum.  
 
What will happen if you take part in the study?
This is what will happen during the study (which will take place while you are being 
interviewed):  
1. The principal investigator for the study, Courtney Kuhl, will arrange an interview with you 
to last approximately one hour.  
2. During the interview, Courtney will ask you questions regarding your views of corporate 
social responsibility, strategic giving, and your company’s initiatives in these areas.   
3. The interview will be recorded for purposes of note taking and to capture quotes. During 
the interview, you have the right to ask that the tape recorder be turned off at any time. 
4. During the interview, you may skip any question you choose for any reason.  
What are the possible benefits from being in this study?
Research is designed to benefit society by gaining new knowledge.  You may not benefit 
personally from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study?
We do not anticipate any risk or discomfort to you in this study. There may be uncommon or 
previously unknown risks.  You should report any problems to the researcher. 
 
How will your privacy be protected?
Participants will not be identified in any report or publication about this study. Although 
every effort will be made to keep research records private, there may be times when federal 
or state law requires the disclosure of such records, including personal information.  This is 
very unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable 
by law to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University, research sponsors, or 
government agencies for purposes such as quality control or safety.    
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• We will not use your name or the name of your corporation in any of the information 
we get from this study or in any of the research reports.  
• Direct quotes from interviews will be used in the final written report for this study. 
All corporate and individual names will be converted to pseudonyms to protect the 
identity of participants.  
• To avoid deductive disclosure of participants, names of specific products, campaigns, 
and other identifying details of both the individuals and corporations will be changed 
to help protect the privacy of participants.  
• Any information we get in the study will be recorded with a code number that will let 
the researcher know who you are.  
• When the study is finished the key that shows which code number goes with your 
name will be destroyed.  
• Recorded tapes of the interviews will be destroyed when the study concludes. 
Will you receive anything for being in this study?
You will not receive anything for taking part in this study. 
 
Will it cost you anything to be in this study?
There will be no costs for being in the study 
 
What if you have questions about this study?
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions, or concerns, you should contact the researchers listed on the 
first page of this form. 
 
What if you have questions about your rights as a research participant?
All research on human volunteers is reviewed by a committee that works to protect your 
rights and welfare.  If you have questions or concerns about your rights as a research subject 
you may contact, anonymously if you wish, the Institutional Review Board at 919-966-3113 
or by email to IRB_subjects@unc.edu. 
 
Participant’s Agreement: 
I have read the information provided above.  I have asked all the questions I have at this time.  
I voluntarily agree to participate in this research study. 
 
_________________________________________   _________________ 
Signature of Research Participant     Date 
 
_________________________________________ 
Printed Name of Research Participant 
 
_________________________________________  _________________ 
Signature of Person Obtaining Consent   Date 
 
_________________________________________ 
Printed Name of Person Obtaining Consent 
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Appendix III: 
 
Recruiting Letter for Interview Participants 
 
Dear XXXX, 
 
Greetings! I hope this letter finds you well. As recommended by XXXX, I am writing you to 
gauge your interest in participating in a research interview at your convenience in the coming 
weeks. I am a graduate student at the University of North Carolina at Chapel Hill, and I am 
currently working on my master’s thesis. The purpose my research is to understand how 
executives at healthcare corporations view corporate giving at their institutions, and how 
giving relates to the corporate social responsibility of the organization.  
 
(Insert additional paragraph of personal greeting depending on the level of acquaintance with 
the potential interviewee.) 
I would be grateful for your of consideration of an interview on this topic. With your 
experience in the industry – and your role at X Healthcare Corporation - your input in this 
study would be invaluable.  
As your schedule permits, I would be delighted to arrange an interview at a location of your 
choosing; I can travel to your office or another convenient location. Should you agree to 
participate, the interview should take about one hour of your time.   
I would be happy to provide additional details about this project and my studies at the School 
of Journalism and Mass Communication, should you be interested. Dr. Elizabeth Dougall is 
the supervising professor of this research study, and she can be contacted at 919.962.6396 if 
you have any questions.  
In the coming days, I will phone your office to follow up on your interest in arranging an 
interview. You may also contact me directly at 703.855.0357 or via email at 
ckuhl@email.unc.edu if you have any questions.  
Thank you for your consideration, and I look forward to speaking with you soon.  
Kind regards, 
 
Courtney Kuhl 
Master’s Student, University of North Carolina at Chapel Hill 
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Appendix IV: 
 
Strength of Findings by Participant 
 
The following chart represents the etic codes, etic sub codes from the research 
findings. Based on the time participants talked about that topic and their enthusiasm for it, I 
assigned each of them a score between one and 10 representing their support for that theme. 
This table provides an overall sense of the strength of the findings.  
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Ben  10 7 8 10 10 10 3  9 8 6 10 4 8 6 
Catherine 7 5 7 7 10    8 7 9 6 6 3 6 7 
Danica  10 8 8 10 10 10 1  9 7  8  6  
Daniel 9  7 8 8    9 7 7 7 6 3 8 7 
Doug 9 5 6 10 7     5  6 4  10 10 
Garrett 9 8 6 9 10 6 6   10 10  6 3 7 10 
John 10  10 9 10 10 10 3  10 10 8 9  10  
Karl 7 5 6 8 9 7   5 6 10 6 6  10 9 
Linda 9 7 7 10 8 8  5 7 10 6 7 7  9 10 
Sally 8 9 9 9 6   3   7  7  8 10 
Sam   10 8 10 10   7 10 6 9 10 3 8  
Total 68 59 83 94 98 61 36 15 36 83 80 55 79 16 90 69 
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